PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_0	[0]	[240]	['Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial\n\nAbstract\nObjective To determine the effect of antenatal dietary and lifestyle interventions on health outcomes in overweight and obese pregnant women.']	women	NCBITAXON_EXT	[31]	[36]	BMJ_2014_Feb_10_348_g1285_T225
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_0	[0]	[240]	['Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial\n\nAbstract\nObjective To determine the effect of antenatal dietary and lifestyle interventions on health outcomes in overweight and obese pregnant women.']	women	UBERON_EXT	[31]	[36]	BMJ_2014_Feb_10_348_g1285_T291
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_0	[0]	[240]	['Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial\n\nAbstract\nObjective To determine the effect of antenatal dietary and lifestyle interventions on health outcomes in overweight and obese pregnant women.']	antenatal	GO_BP_EXT	[136]	[145]	BMJ_2014_Feb_10_348_g1285_T28
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_0	[0]	[240]	['Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial\n\nAbstract\nObjective To determine the effect of antenatal dietary and lifestyle interventions on health outcomes in overweight and obese pregnant women.']	pregnant	GO_BP_EXT	[225]	[233]	BMJ_2014_Feb_10_348_g1285_T29
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_0	[0]	[240]	['Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial\n\nAbstract\nObjective To determine the effect of antenatal dietary and lifestyle interventions on health outcomes in overweight and obese pregnant women.']	women	NCBITAXON_EXT	[234]	[239]	BMJ_2014_Feb_10_348_g1285_T226
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_2	[278]	[468]	['We utilised a central telephone randomisation server, with computer generated schedule, balanced variable blocks, and stratification for parity, body mass index (BMI) category, and hospital.']	body	UBERON_EXT	[423]	[427]	BMJ_2014_Feb_10_348_g1285_T292
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_4	[534]	[638]	['Participants 2212 women with a singleton pregnancy, between 10+0 and 20+0 weeks’ gestation, and BMI ≥25.']	women	NCBITAXON_EXT	[552]	[557]	BMJ_2014_Feb_10_348_g1285_T227
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_4	[534]	[638]	['Participants 2212 women with a singleton pregnancy, between 10+0 and 20+0 weeks’ gestation, and BMI ≥25.']	pregnancy	GO_BP_EXT	[575]	[584]	BMJ_2014_Feb_10_348_g1285_T30
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_4	[534]	[638]	['Participants 2212 women with a singleton pregnancy, between 10+0 and 20+0 weeks’ gestation, and BMI ≥25.']	gestation	GO_BP_EXT	[615]	[624]	BMJ_2014_Feb_10_348_g1285_T31
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_5	[639]	[899]	['Interventions 1108 women were randomised to a comprehensive dietary and lifestyle intervention delivered by research staff; 1104 were randomised to standard care and received pregnancy care according to local guidelines, which did not include such information.']	women	NCBITAXON_EXT	[658]	[663]	BMJ_2014_Feb_10_348_g1285_T228
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_5	[639]	[899]	['Interventions 1108 women were randomised to a comprehensive dietary and lifestyle intervention delivered by research staff; 1104 were randomised to standard care and received pregnancy care according to local guidelines, which did not include such information.']	women	UBERON_EXT	[658]	[663]	BMJ_2014_Feb_10_348_g1285_T293
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_5	[639]	[899]	['Interventions 1108 women were randomised to a comprehensive dietary and lifestyle intervention delivered by research staff; 1104 were randomised to standard care and received pregnancy care according to local guidelines, which did not include such information.']	pregnancy	GO_BP_EXT	[814]	[823]	BMJ_2014_Feb_10_348_g1285_T32
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_6	[900]	[1025]	['Main outcome measures Incidence of infants born large for gestational age (birth weight ≥90th centile for gestation and sex).']	born	GO_BP_EXT	[943]	[947]	BMJ_2014_Feb_10_348_g1285_T33
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_6	[900]	[1025]	['Main outcome measures Incidence of infants born large for gestational age (birth weight ≥90th centile for gestation and sex).']	gestational	GO_BP_EXT	[958]	[969]	BMJ_2014_Feb_10_348_g1285_T34
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_6	[900]	[1025]	['Main outcome measures Incidence of infants born large for gestational age (birth weight ≥90th centile for gestation and sex).']	birth	GO_BP_EXT	[975]	[980]	BMJ_2014_Feb_10_348_g1285_T35
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_6	[900]	[1025]	['Main outcome measures Incidence of infants born large for gestational age (birth weight ≥90th centile for gestation and sex).']	gestation	GO_BP_EXT	[1006]	[1015]	BMJ_2014_Feb_10_348_g1285_T36
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_7	[1026]	[1143]	['Prespecified secondary outcomes included birth weight >4000 g, hypertension, pre-eclampsia, and gestational diabetes.']	birth	GO_BP_EXT	[1067]	[1072]	BMJ_2014_Feb_10_348_g1285_T37
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_7	[1026]	[1143]	['Prespecified secondary outcomes included birth weight >4000 g, hypertension, pre-eclampsia, and gestational diabetes.']	gestational	GO_BP_EXT	[1122]	[1133]	BMJ_2014_Feb_10_348_g1285_T38
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_9	[1189]	[1264]	['Results 2152 women and 2142 liveborn infants were included in the analyses.']	women	NCBITAXON_EXT	[1202]	[1207]	BMJ_2014_Feb_10_348_g1285_T229
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_9	[1189]	[1264]	['Results 2152 women and 2142 liveborn infants were included in the analyses.']	women	UBERON_EXT	[1202]	[1207]	BMJ_2014_Feb_10_348_g1285_T294
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_9	[1189]	[1264]	['Results 2152 women and 2142 liveborn infants were included in the analyses.']	infants	UBERON_EXT	[1226]	[1233]	BMJ_2014_Feb_10_348_g1285_T295
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_10	[1265]	[1510]	['The risk of the infant being large for gestational age was not significantly different in the two groups (lifestyle advice 203/1075 (19%) v standard care 224/1067 (21%); adjusted relative risk 0.90, 95% confidence interval 0.77 to 1.07; P=0.24).']	infant	UBERON_EXT	[1281]	[1287]	BMJ_2014_Feb_10_348_g1285_T296
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_10	[1265]	[1510]	['The risk of the infant being large for gestational age was not significantly different in the two groups (lifestyle advice 203/1075 (19%) v standard care 224/1067 (21%); adjusted relative risk 0.90, 95% confidence interval 0.77 to 1.07; P=0.24).']	gestational	GO_BP_EXT	[1304]	[1315]	BMJ_2014_Feb_10_348_g1285_T39
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_11	[1511]	[1758]	['Infants born to women after lifestyle advice were significantly less likely to have birth weight above 4000 g (lifestyle advice 164/1075 (15%) v standard care 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04).']	born	GO_BP_EXT	[1519]	[1523]	BMJ_2014_Feb_10_348_g1285_T40
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_11	[1511]	[1758]	['Infants born to women after lifestyle advice were significantly less likely to have birth weight above 4000 g (lifestyle advice 164/1075 (15%) v standard care 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04).']	women	NCBITAXON_EXT	[1527]	[1532]	BMJ_2014_Feb_10_348_g1285_T230
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_11	[1511]	[1758]	['Infants born to women after lifestyle advice were significantly less likely to have birth weight above 4000 g (lifestyle advice 164/1075 (15%) v standard care 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04).']	women	UBERON_EXT	[1527]	[1532]	BMJ_2014_Feb_10_348_g1285_T297
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_11	[1511]	[1758]	['Infants born to women after lifestyle advice were significantly less likely to have birth weight above 4000 g (lifestyle advice 164/1075 (15%) v standard care 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04).']	birth	GO_BP_EXT	[1595]	[1600]	BMJ_2014_Feb_10_348_g1285_T41
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_12	[1759]	[1859]	['There were no differences in maternal pregnancy and birth outcomes between the two treatment groups.']	pregnancy	GO_BP_EXT	[1797]	[1806]	BMJ_2014_Feb_10_348_g1285_T42
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_12	[1759]	[1859]	['There were no differences in maternal pregnancy and birth outcomes between the two treatment groups.']	birth	GO_BP_EXT	[1811]	[1816]	BMJ_2014_Feb_10_348_g1285_T43
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_13	[1860]	[2113]	['Conclusions For women who were overweight or obese, the antenatal lifestyle advice used in this study did not reduce the risk delivering a baby weighing above the 90th centile for gestational age and sex or improve maternal pregnancy and birth outcomes.']	women	NCBITAXON_EXT	[1876]	[1881]	BMJ_2014_Feb_10_348_g1285_T231
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_13	[1860]	[2113]	['Conclusions For women who were overweight or obese, the antenatal lifestyle advice used in this study did not reduce the risk delivering a baby weighing above the 90th centile for gestational age and sex or improve maternal pregnancy and birth outcomes.']	women	UBERON_EXT	[1876]	[1881]	BMJ_2014_Feb_10_348_g1285_T298
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_13	[1860]	[2113]	['Conclusions For women who were overweight or obese, the antenatal lifestyle advice used in this study did not reduce the risk delivering a baby weighing above the 90th centile for gestational age and sex or improve maternal pregnancy and birth outcomes.']	delivering	GO_BP_EXT	[1986]	[1996]	BMJ_2014_Feb_10_348_g1285_T44
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_13	[1860]	[2113]	['Conclusions For women who were overweight or obese, the antenatal lifestyle advice used in this study did not reduce the risk delivering a baby weighing above the 90th centile for gestational age and sex or improve maternal pregnancy and birth outcomes.']	baby	UBERON_EXT	[1999]	[2003]	BMJ_2014_Feb_10_348_g1285_T299
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_13	[1860]	[2113]	['Conclusions For women who were overweight or obese, the antenatal lifestyle advice used in this study did not reduce the risk delivering a baby weighing above the 90th centile for gestational age and sex or improve maternal pregnancy and birth outcomes.']	gestational	GO_BP_EXT	[2040]	[2051]	BMJ_2014_Feb_10_348_g1285_T45
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_13	[1860]	[2113]	['Conclusions For women who were overweight or obese, the antenatal lifestyle advice used in this study did not reduce the risk delivering a baby weighing above the 90th centile for gestational age and sex or improve maternal pregnancy and birth outcomes.']	pregnancy	GO_BP_EXT	[2084]	[2093]	BMJ_2014_Feb_10_348_g1285_T46
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_13	[1860]	[2113]	['Conclusions For women who were overweight or obese, the antenatal lifestyle advice used in this study did not reduce the risk delivering a baby weighing above the 90th centile for gestational age and sex or improve maternal pregnancy and birth outcomes.']	birth	GO_BP_EXT	[2098]	[2103]	BMJ_2014_Feb_10_348_g1285_T47
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	cardiovascular	UBERON_EXT	[2384]	[2398]	BMJ_2014_Feb_10_348_g1285_T300
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	pregnancy	GO_BP_EXT	[2500]	[2509]	BMJ_2014_Feb_10_348_g1285_T48
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	women	NCBITAXON_EXT	[2530]	[2535]	BMJ_2014_Feb_10_348_g1285_T232
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	women	UBERON_EXT	[2530]	[2535]	BMJ_2014_Feb_10_348_g1285_T301
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	pregnancy	GO_BP_EXT	[2545]	[2554]	BMJ_2014_Feb_10_348_g1285_T49
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	body	UBERON_EXT	[2562]	[2566]	BMJ_2014_Feb_10_348_g1285_T302
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	pregnancy	GO_BP_EXT	[2647]	[2656]	BMJ_2014_Feb_10_348_g1285_T50
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	labour	GO_BP_EXT	[2849]	[2855]	BMJ_2014_Feb_10_348_g1285_T51
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	perinatal	GO_BP_EXT	[2885]	[2894]	BMJ_2014_Feb_10_348_g1285_T52
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	perinatal	UBERON_EXT	[2885]	[2894]	BMJ_2014_Feb_10_348_g1285_T303
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	death	GO_BP_EXT	[2895]	[2900]	BMJ_2014_Feb_10_348_g1285_T53
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	born	GO_BP_EXT	[2911]	[2915]	BMJ_2014_Feb_10_348_g1285_T54
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	women	NCBITAXON_EXT	[2939]	[2944]	BMJ_2014_Feb_10_348_g1285_T233
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	infant	UBERON_EXT	[3169]	[3175]	BMJ_2014_Feb_10_348_g1285_T304
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	birth	GO_BP_EXT	[3176]	[3181]	BMJ_2014_Feb_10_348_g1285_T55
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	birth	GO_BP_EXT	[3210]	[3215]	BMJ_2014_Feb_10_348_g1285_T56
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	gestational	GO_BP_EXT	[3250]	[3261]	BMJ_2014_Feb_10_348_g1285_T57
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	birth	GO_BP_EXT	[3269]	[3274]	BMJ_2014_Feb_10_348_g1285_T58
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	infant10and	UBERON_EXT	[3361]	[3372]	BMJ_2014_Feb_10_348_g1285_T305
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	childhood	UBERON_EXT	[3373]	[3382]	BMJ_2014_Feb_10_348_g1285_T306
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	pregnancy	GO_BP_EXT	[3444]	[3453]	BMJ_2014_Feb_10_348_g1285_T59
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	gestational	GO_BP_EXT	[3593]	[3604]	BMJ_2014_Feb_10_348_g1285_T60
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	pregnancy	GO_BP_EXT	[3620]	[3629]	BMJ_2014_Feb_10_348_g1285_T61
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	women	NCBITAXON_EXT	[3643]	[3648]	BMJ_2014_Feb_10_348_g1285_T234
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	women	UBERON_EXT	[3643]	[3648]	BMJ_2014_Feb_10_348_g1285_T307
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	infants	UBERON_EXT	[3864]	[3871]	BMJ_2014_Feb_10_348_g1285_T308
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	born	GO_BP_EXT	[3878]	[3882]	BMJ_2014_Feb_10_348_g1285_T62
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	gestational	GO_BP_EXT	[3893]	[3904]	BMJ_2014_Feb_10_348_g1285_T63
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	women	NCBITAXON_EXT	[4014]	[4019]	BMJ_2014_Feb_10_348_g1285_T235
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	women	UBERON_EXT	[4014]	[4019]	BMJ_2014_Feb_10_348_g1285_T309
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	gestational	GO_BP_EXT	[4083]	[4094]	BMJ_2014_Feb_10_348_g1285_T64
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	pregnancy	GO_BP_EXT	[4240]	[4249]	BMJ_2014_Feb_10_348_g1285_T65
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_15	[2209]	[4265]	['Introduction\nThe World Health Organization has identified obesity as a health problem of global importance,1contributing to the burden of disease through an increased risk of cardiovascular disease and diabetes and their complications.2Overweight and obesity are commonly encountered during pregnancy, with about half of women entering pregnancy with a body mass index (BMI) ≥25.34\nThe risks associated with overweight and obesity during pregnancy are well documented and increase with increasing BMI.56Maternal complications include an increased risk of hypertension and pre-eclampsia,567gestational diabetes,567need for both induction of labour and caesarean section,567and perinatal death.89Infants born to overweight or obese women are more likely to be macrosomic,6789be admitted to intensive care,569and require treatment for jaundice or hypoglycaemia.56Furthermore, population studies consistently identify both maternal overweight and obesity and high infant birth weight (variably defined as birth weight above the 90th centile for gestational age or birth weight above 4000 g or 4500 g) as important risk factors for the development of early infant10and childhood obesity.11\nSubstantial literature on maternal weight gain in pregnancy has been summarised by the Institute of Medicine.12Several population based cohort studies have evaluated the effect of varying degrees of gestational weight gain on pregnancy outcomes for women who are overweight or obese, suggesting that, compared with higher weight gain, weight gain within the recommendations of the Institute of Medicine is associated with a reduced risk of maternal complications and of infants being born large for gestational age.13141516Most small randomised trials to date evaluating antenatal dietary and lifestyle interventions in women who are overweight or obese have primarily focused on limiting gestational weight gain, often as a surrogate measure for clinical outcomes, based on the assumption that lower weight gain will in turn improve outcomes in pregnancy and childbirth.']	childbirth	GO_BP_EXT	[4254]	[4264]	BMJ_2014_Feb_10_348_g1285_T66
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_16	[4266]	[4670]	['While meta-analyses indicate that interventions seem effective in limiting gestational weight gain, the effect on maternal and perinatal outcomes, which have been under-reported, remains to be determined.171819\nWe conducted a randomised trial to evaluate whether provision of antenatal lifestyle advice to overweight or obese pregnant women was effective in improving maternal and infant health outcomes.']	gestational	GO_BP_EXT	[4341]	[4352]	BMJ_2014_Feb_10_348_g1285_T67
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_16	[4266]	[4670]	['While meta-analyses indicate that interventions seem effective in limiting gestational weight gain, the effect on maternal and perinatal outcomes, which have been under-reported, remains to be determined.171819\nWe conducted a randomised trial to evaluate whether provision of antenatal lifestyle advice to overweight or obese pregnant women was effective in improving maternal and infant health outcomes.']	perinatal	GO_BP_EXT	[4393]	[4402]	BMJ_2014_Feb_10_348_g1285_T68
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_16	[4266]	[4670]	['While meta-analyses indicate that interventions seem effective in limiting gestational weight gain, the effect on maternal and perinatal outcomes, which have been under-reported, remains to be determined.171819\nWe conducted a randomised trial to evaluate whether provision of antenatal lifestyle advice to overweight or obese pregnant women was effective in improving maternal and infant health outcomes.']	perinatal	UBERON_EXT	[4393]	[4402]	BMJ_2014_Feb_10_348_g1285_T310
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_16	[4266]	[4670]	['While meta-analyses indicate that interventions seem effective in limiting gestational weight gain, the effect on maternal and perinatal outcomes, which have been under-reported, remains to be determined.171819\nWe conducted a randomised trial to evaluate whether provision of antenatal lifestyle advice to overweight or obese pregnant women was effective in improving maternal and infant health outcomes.']	antenatal	GO_BP_EXT	[4542]	[4551]	BMJ_2014_Feb_10_348_g1285_T69
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_16	[4266]	[4670]	['While meta-analyses indicate that interventions seem effective in limiting gestational weight gain, the effect on maternal and perinatal outcomes, which have been under-reported, remains to be determined.171819\nWe conducted a randomised trial to evaluate whether provision of antenatal lifestyle advice to overweight or obese pregnant women was effective in improving maternal and infant health outcomes.']	pregnant	GO_BP_EXT	[4592]	[4600]	BMJ_2014_Feb_10_348_g1285_T70
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_16	[4266]	[4670]	['While meta-analyses indicate that interventions seem effective in limiting gestational weight gain, the effect on maternal and perinatal outcomes, which have been under-reported, remains to be determined.171819\nWe conducted a randomised trial to evaluate whether provision of antenatal lifestyle advice to overweight or obese pregnant women was effective in improving maternal and infant health outcomes.']	women	NCBITAXON_EXT	[4601]	[4606]	BMJ_2014_Feb_10_348_g1285_T236
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_16	[4266]	[4670]	['While meta-analyses indicate that interventions seem effective in limiting gestational weight gain, the effect on maternal and perinatal outcomes, which have been under-reported, remains to be determined.171819\nWe conducted a randomised trial to evaluate whether provision of antenatal lifestyle advice to overweight or obese pregnant women was effective in improving maternal and infant health outcomes.']	infant	UBERON_EXT	[4647]	[4653]	BMJ_2014_Feb_10_348_g1285_T311
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_17	[4672]	[4838]	['Methods\n\nParticipants\nWomen were recruited between June 2008 and December 2011 from the three major metropolitan maternity hospitals within Adelaide, South Australia.']	Women	NCBITAXON_EXT	[4694]	[4699]	BMJ_2014_Feb_10_348_g1285_T237
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_17	[4672]	[4838]	['Methods\n\nParticipants\nWomen were recruited between June 2008 and December 2011 from the three major metropolitan maternity hospitals within Adelaide, South Australia.']	Women	UBERON_EXT	[4694]	[4699]	BMJ_2014_Feb_10_348_g1285_T312
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_18	[4839]	[4939]	['Women were eligible if they had a BMI ≥ 25 and singleton pregnancy at 10+0 to 20+0 weeks’ gestation.']	Women	NCBITAXON_EXT	[4839]	[4844]	BMJ_2014_Feb_10_348_g1285_T238
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_18	[4839]	[4939]	['Women were eligible if they had a BMI ≥ 25 and singleton pregnancy at 10+0 to 20+0 weeks’ gestation.']	pregnancy	GO_BP_EXT	[4896]	[4905]	BMJ_2014_Feb_10_348_g1285_T71
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_18	[4839]	[4939]	['Women were eligible if they had a BMI ≥ 25 and singleton pregnancy at 10+0 to 20+0 weeks’ gestation.']	gestation	GO_BP_EXT	[4929]	[4938]	BMJ_2014_Feb_10_348_g1285_T72
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_19	[4940]	[5015]	['Women with type 1 or 2 diabetes diagnosed before pregnancy were ineligible.']	Women	NCBITAXON_EXT	[4940]	[4945]	BMJ_2014_Feb_10_348_g1285_T239
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_19	[4940]	[5015]	['Women with type 1 or 2 diabetes diagnosed before pregnancy were ineligible.']	Women	UBERON_EXT	[4940]	[4945]	BMJ_2014_Feb_10_348_g1285_T313
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_19	[4940]	[5015]	['Women with type 1 or 2 diabetes diagnosed before pregnancy were ineligible.']	pregnancy	GO_BP_EXT	[4989]	[4998]	BMJ_2014_Feb_10_348_g1285_T73
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_20	[5016]	[5373]	['Each participant provided written informed consent, and the ethics committee at each collaborating hospital approved the protocol.20\n\nRandomisation, allocation concealment, and blinding\nAll pregnant women presenting for antenatal care at the participating centres had their height and weight measured and BMI calculated at their first antenatal appointment.']	pregnant	GO_BP_EXT	[5206]	[5214]	BMJ_2014_Feb_10_348_g1285_T74
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_20	[5016]	[5373]	['Each participant provided written informed consent, and the ethics committee at each collaborating hospital approved the protocol.20\n\nRandomisation, allocation concealment, and blinding\nAll pregnant women presenting for antenatal care at the participating centres had their height and weight measured and BMI calculated at their first antenatal appointment.']	women	NCBITAXON_EXT	[5215]	[5220]	BMJ_2014_Feb_10_348_g1285_T240
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_21	[5374]	[5540]	['A research assistant counselled eligible women and then randomised them to receive lifestyle advice or standard care by telephoning the central randomisation service.']	women	NCBITAXON_EXT	[5415]	[5420]	BMJ_2014_Feb_10_348_g1285_T241
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_21	[5374]	[5540]	['A research assistant counselled eligible women and then randomised them to receive lifestyle advice or standard care by telephoning the central randomisation service.']	women	UBERON_EXT	[5415]	[5420]	BMJ_2014_Feb_10_348_g1285_T314
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_21	[5374]	[5540]	['A research assistant counselled eligible women and then randomised them to receive lifestyle advice or standard care by telephoning the central randomisation service.']	lifestyle	GO_BP_EXT	[5457]	[5466]	BMJ_2014_Feb_10_348_g1285_T75
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	Women	NCBITAXON_EXT	[5927]	[5932]	BMJ_2014_Feb_10_348_g1285_T242
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	Women	UBERON_EXT	[5927]	[5932]	BMJ_2014_Feb_10_348_g1285_T315
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	pregnancy	GO_BP_EXT	[6059]	[6068]	BMJ_2014_Feb_10_348_g1285_T76
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	carbohydrates	CHEBI_EXT	[6325]	[6338]	BMJ_2014_Feb_10_348_g1285_T0
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	fat	CHEBI_EXT	[6340]	[6343]	BMJ_2014_Feb_10_348_g1285_T1
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	protein	CHEBI_EXT	[6349]	[6356]	BMJ_2014_Feb_10_348_g1285_T2
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	protein	CHEBI_EXT	[6349]	[6356]	BMJ_2014_Feb_10_348_g1285_T290
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	foods	CHEBI_EXT	[6381]	[6386]	BMJ_2014_Feb_10_348_g1285_T3
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	carbohydrates	CHEBI_EXT	[6403]	[6416]	BMJ_2014_Feb_10_348_g1285_T4
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	saturated fats	CHEBI_EXT	[6421]	[6435]	BMJ_2014_Feb_10_348_g1285_T5
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	fats	CHEBI_EXT	[6431]	[6435]	BMJ_2014_Feb_10_348_g1285_T316
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	consumption	GO_BP_EXT	[6484]	[6495]	BMJ_2014_Feb_10_348_g1285_T77
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	women	NCBITAXON_EXT	[6636]	[6641]	BMJ_2014_Feb_10_348_g1285_T243
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	women	UBERON_EXT	[6636]	[6641]	BMJ_2014_Feb_10_348_g1285_T317
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	decision making	GO_BP_EXT	[6775]	[6790]	BMJ_2014_Feb_10_348_g1285_T78
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	women	NCBITAXON_EXT	[6829]	[6834]	BMJ_2014_Feb_10_348_g1285_T244
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_25	[5897]	[6956]	['Intervention—lifestyle advice\nWomen randomised to lifestyle advice participated in a comprehensive dietary and lifestyle intervention over the remainder of their pregnancy that included a combination of dietary, exercise, and behavioural strategies delivered by a research dietician and trained research assistants.20Women were provided with dietary advice consistent with current Australian standards21to maintain a balance of carbohydrates, fat, and protein and to reduce intake of foods high in refined carbohydrates and saturated fats, while increasing intake of fibre and promoting consumption of two servings of fruit, five servings of vegetables, and three servings of dairy each day.21Physical activity advice primarily encouraged women to increase their amount of walking and incidental activity.22Tailoring of the intervention was informed by stage theories of health decision making.23\nWithin two weeks of randomisation, women attended a planning session with a research dietician, during which a detailed dietary and exercise history was obtained.']	women	UBERON_EXT	[6829]	[6834]	BMJ_2014_Feb_10_348_g1285_T318
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	Women	NCBITAXON_EXT	[6957]	[6962]	BMJ_2014_Feb_10_348_g1285_T245
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	Women	UBERON_EXT	[6957]	[6962]	BMJ_2014_Feb_10_348_g1285_T319
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	food	CHEBI_EXT	[7083]	[7087]	BMJ_2014_Feb_10_348_g1285_T6
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	sugar	CHEBI_EXT	[7122]	[7127]	BMJ_2014_Feb_10_348_g1285_T7
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	soft drinks	CHEBI_EXT	[7138]	[7149]	BMJ_2014_Feb_10_348_g1285_T8
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	sugar	CHEBI_EXT	[7183]	[7188]	BMJ_2014_Feb_10_348_g1285_T9
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	foods	CHEBI_EXT	[7193]	[7198]	BMJ_2014_Feb_10_348_g1285_T10
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	carbohydrates	CHEBI_EXT	[7215]	[7228]	BMJ_2014_Feb_10_348_g1285_T11
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	fat	CHEBI_EXT	[7238]	[7241]	BMJ_2014_Feb_10_348_g1285_T12
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	fat	CHEBI_EXT	[7238]	[7241]	BMJ_2014_Feb_10_348_g1285_T320
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	snacking	GO_BP_EXT	[7277]	[7285]	BMJ_2014_Feb_10_348_g1285_T79
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	eating	GO_BP_EXT	[7290]	[7296]	BMJ_2014_Feb_10_348_g1285_T80
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	food	CHEBI_EXT	[7329]	[7333]	BMJ_2014_Feb_10_348_g1285_T13
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_26	[6957]	[7346]	['Women were provided with individualised information, including meal plans, healthy recipes that were quick to prepare, simple food substitutions (including reducing sugar sweetened soft drinks and fruit juices, reducing added sugar and foods high in refined carbohydrates, and low fat alternatives), options for healthy snacking and eating out, and guidelines for healthy food preparation.']	food preparation	GO_BP_EXT	[7329]	[7345]	BMJ_2014_Feb_10_348_g1285_T81
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_27	[7347]	[7550]	['Women were encouraged to set achievable goals for dietary and exercise change, supported to make these lifestyle changes, and asked to self monitor their progress through the use of a work book provided.']	Women	NCBITAXON_EXT	[7347]	[7352]	BMJ_2014_Feb_10_348_g1285_T246
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_27	[7347]	[7550]	['Women were encouraged to set achievable goals for dietary and exercise change, supported to make these lifestyle changes, and asked to self monitor their progress through the use of a work book provided.']	Women	UBERON_EXT	[7347]	[7352]	BMJ_2014_Feb_10_348_g1285_T321
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_28	[7551]	[7667]	['Women were encouraged to identify potential barriers to implementation of their dietary and physical activity goals.']	Women	NCBITAXON_EXT	[7551]	[7556]	BMJ_2014_Feb_10_348_g1285_T247
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_28	[7551]	[7667]	['Women were encouraged to identify potential barriers to implementation of their dietary and physical activity goals.']	Women	UBERON_EXT	[7551]	[7556]	BMJ_2014_Feb_10_348_g1285_T322
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_29	[7668]	[7824]	['Using these perceived barriers, women were assisted to problem solve and to develop individualised strategies to facilitate their successful implementation.']	women	NCBITAXON_EXT	[7700]	[7705]	BMJ_2014_Feb_10_348_g1285_T248
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_29	[7668]	[7824]	['Using these perceived barriers, women were assisted to problem solve and to develop individualised strategies to facilitate their successful implementation.']	women	UBERON_EXT	[7700]	[7705]	BMJ_2014_Feb_10_348_g1285_T323
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_30	[7825]	[8078]	['This information was reinforced during subsequent inputs provided by the research dietician (at 28 weeks’ gestation) and trained research assistants (via telephone call at 22, 24, and 32 weeks’ gestation and a face to face visit at 36 weeks’ gestation).']	gestation	GO_BP_EXT	[7931]	[7940]	BMJ_2014_Feb_10_348_g1285_T82
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_30	[7825]	[8078]	['This information was reinforced during subsequent inputs provided by the research dietician (at 28 weeks’ gestation) and trained research assistants (via telephone call at 22, 24, and 32 weeks’ gestation and a face to face visit at 36 weeks’ gestation).']	gestation	GO_BP_EXT	[8019]	[8028]	BMJ_2014_Feb_10_348_g1285_T83
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_30	[7825]	[8078]	['This information was reinforced during subsequent inputs provided by the research dietician (at 28 weeks’ gestation) and trained research assistants (via telephone call at 22, 24, and 32 weeks’ gestation and a face to face visit at 36 weeks’ gestation).']	gestation	GO_BP_EXT	[8067]	[8076]	BMJ_2014_Feb_10_348_g1285_T84
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	Women	NCBITAXON_EXT	[8094]	[8099]	BMJ_2014_Feb_10_348_g1285_T249
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	Women	UBERON_EXT	[8094]	[8099]	BMJ_2014_Feb_10_348_g1285_T324
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	pregnancy	GO_BP_EXT	[8155]	[8164]	BMJ_2014_Feb_10_348_g1285_T85
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	perinatal	GO_BP_EXT	[8194]	[8203]	BMJ_2014_Feb_10_348_g1285_T86
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	perinatal	UBERON_EXT	[8194]	[8203]	BMJ_2014_Feb_10_348_g1285_T325
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	gestational	GO_BP_EXT	[8355]	[8366]	BMJ_2014_Feb_10_348_g1285_T87
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	women	NCBITAXON_EXT	[8396]	[8401]	BMJ_2014_Feb_10_348_g1285_T250
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	women	UBERON_EXT	[8396]	[8401]	BMJ_2014_Feb_10_348_g1285_T326
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	women	NCBITAXON_EXT	[8421]	[8426]	BMJ_2014_Feb_10_348_g1285_T251
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	women	UBERON_EXT	[8421]	[8426]	BMJ_2014_Feb_10_348_g1285_T327
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_31	[8080]	[8517]	['Standard care\nWomen randomised to standard care continued to receive their pregnancy care according to state-wide perinatal practice and local hospital guidelines, which during the course of the trial did not include routine provision of advice related to diet, exercise, or gestational weight gain.24\n\nFollow-up of women in both groups\nAll women had their ongoing clinical care provided by clinicians at their planned hospital of birth.']	birth	GO_BP_EXT	[8511]	[8516]	BMJ_2014_Feb_10_348_g1285_T88
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_32	[8518]	[8844]	['Consistent with state-wide perinatal practices, all women were encouraged to undergo screening for gestational diabetes.25After birth, a research assistant not involved in providing the intervention and blinded to treatment allocation obtained information relating to antenatal, birth, and infant outcomes from the case notes.']	perinatal	GO_BP_EXT	[8545]	[8554]	BMJ_2014_Feb_10_348_g1285_T89
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_32	[8518]	[8844]	['Consistent with state-wide perinatal practices, all women were encouraged to undergo screening for gestational diabetes.25After birth, a research assistant not involved in providing the intervention and blinded to treatment allocation obtained information relating to antenatal, birth, and infant outcomes from the case notes.']	perinatal	UBERON_EXT	[8545]	[8554]	BMJ_2014_Feb_10_348_g1285_T328
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_32	[8518]	[8844]	['Consistent with state-wide perinatal practices, all women were encouraged to undergo screening for gestational diabetes.25After birth, a research assistant not involved in providing the intervention and blinded to treatment allocation obtained information relating to antenatal, birth, and infant outcomes from the case notes.']	women	NCBITAXON_EXT	[8570]	[8575]	BMJ_2014_Feb_10_348_g1285_T252
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_32	[8518]	[8844]	['Consistent with state-wide perinatal practices, all women were encouraged to undergo screening for gestational diabetes.25After birth, a research assistant not involved in providing the intervention and blinded to treatment allocation obtained information relating to antenatal, birth, and infant outcomes from the case notes.']	women	UBERON_EXT	[8570]	[8575]	BMJ_2014_Feb_10_348_g1285_T329
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_32	[8518]	[8844]	['Consistent with state-wide perinatal practices, all women were encouraged to undergo screening for gestational diabetes.25After birth, a research assistant not involved in providing the intervention and blinded to treatment allocation obtained information relating to antenatal, birth, and infant outcomes from the case notes.']	gestational	GO_BP_EXT	[8617]	[8628]	BMJ_2014_Feb_10_348_g1285_T90
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_32	[8518]	[8844]	['Consistent with state-wide perinatal practices, all women were encouraged to undergo screening for gestational diabetes.25After birth, a research assistant not involved in providing the intervention and blinded to treatment allocation obtained information relating to antenatal, birth, and infant outcomes from the case notes.']	birth	GO_BP_EXT	[8646]	[8651]	BMJ_2014_Feb_10_348_g1285_T91
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_32	[8518]	[8844]	['Consistent with state-wide perinatal practices, all women were encouraged to undergo screening for gestational diabetes.25After birth, a research assistant not involved in providing the intervention and blinded to treatment allocation obtained information relating to antenatal, birth, and infant outcomes from the case notes.']	birth	GO_BP_EXT	[8797]	[8802]	BMJ_2014_Feb_10_348_g1285_T92
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_32	[8518]	[8844]	['Consistent with state-wide perinatal practices, all women were encouraged to undergo screening for gestational diabetes.25After birth, a research assistant not involved in providing the intervention and blinded to treatment allocation obtained information relating to antenatal, birth, and infant outcomes from the case notes.']	infant	UBERON_EXT	[8808]	[8814]	BMJ_2014_Feb_10_348_g1285_T330
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	infants	UBERON_EXT	[8896]	[8903]	BMJ_2014_Feb_10_348_g1285_T331
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	born	GO_BP_EXT	[8904]	[8908]	BMJ_2014_Feb_10_348_g1285_T93
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	gestational	GO_BP_EXT	[8919]	[8930]	BMJ_2014_Feb_10_348_g1285_T94
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	birth	GO_BP_EXT	[8936]	[8941]	BMJ_2014_Feb_10_348_g1285_T95
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	gestational	GO_BP_EXT	[8967]	[8978]	BMJ_2014_Feb_10_348_g1285_T96
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	infant	UBERON_EXT	[8987]	[8993]	BMJ_2014_Feb_10_348_g1285_T332
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	gestational	GO_BP_EXT	[9017]	[9028]	BMJ_2014_Feb_10_348_g1285_T97
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	infant	UBERON_EXT	[9039]	[9045]	BMJ_2014_Feb_10_348_g1285_T333
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	birth	GO_BP_EXT	[9046]	[9051]	BMJ_2014_Feb_10_348_g1285_T98
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	infant	UBERON_EXT	[9064]	[9070]	BMJ_2014_Feb_10_348_g1285_T334
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	birth	GO_BP_EXT	[9103]	[9108]	BMJ_2014_Feb_10_348_g1285_T99
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	gestational	GO_BP_EXT	[9210]	[9221]	BMJ_2014_Feb_10_348_g1285_T100
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	growth	GO_BP_EXT	[9320]	[9326]	BMJ_2014_Feb_10_348_g1285_T101
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	pregnancy	GO_BP_EXT	[9334]	[9343]	BMJ_2014_Feb_10_348_g1285_T102
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	infant	UBERON_EXT	[9381]	[9387]	BMJ_2014_Feb_10_348_g1285_T335
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_33	[8846]	[9437]	['Outcomes\nThe primary outcome was the incidence of infants born large for gestational age (birth weight ≥90th centile for gestational age and infant sex).26While large for gestational age, high infant birth weight, and infant macrosomia (variably defined as birth weight above 4000 g or 4500 g) are often used clinically, incorporation of a birthweight centile for gestational age was considered important, reflecting the possibility that the intervention might modify fetal growth across pregnancy and therefore plausibly mediate high infant birth weight across the gestational age spectrum.']	gestational	GO_BP_EXT	[9412]	[9423]	BMJ_2014_Feb_10_348_g1285_T103
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	infant	UBERON_EXT	[9461]	[9467]	BMJ_2014_Feb_10_348_g1285_T336
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	birth	GO_BP_EXT	[9494]	[9499]	BMJ_2014_Feb_10_348_g1285_T104
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	intrauterine	UBERON_EXT	[9542]	[9554]	BMJ_2014_Feb_10_348_g1285_T337
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	death	GO_BP_EXT	[9561]	[9566]	BMJ_2014_Feb_10_348_g1285_T105
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	gestation	GO_BP_EXT	[9583]	[9592]	BMJ_2014_Feb_10_348_g1285_T106
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	birth	GO_BP_EXT	[9604]	[9609]	BMJ_2014_Feb_10_348_g1285_T107
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	death	GO_BP_EXT	[9622]	[9627]	BMJ_2014_Feb_10_348_g1285_T108
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	death	GO_BP_EXT	[9629]	[9634]	BMJ_2014_Feb_10_348_g1285_T109
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	infant	UBERON_EXT	[9649]	[9655]	BMJ_2014_Feb_10_348_g1285_T338
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	lethal	GO_BP_EXT	[9693]	[9699]	BMJ_2014_Feb_10_348_g1285_T110
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	neonatal	UBERON_EXT	[9800]	[9808]	BMJ_2014_Feb_10_348_g1285_T339
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	baby	UBERON_EXT	[9845]	[9849]	BMJ_2014_Feb_10_348_g1285_T340
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	nerve	UBERON_EXT	[9900]	[9905]	BMJ_2014_Feb_10_348_g1285_T341
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	peripheral nerve	UBERON_EXT	[9913]	[9929]	BMJ_2014_Feb_10_348_g1285_T342
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	spinal cord	UBERON_EXT	[9948]	[9959]	BMJ_2014_Feb_10_348_g1285_T343
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	skull	UBERON_EXT	[10021]	[10026]	BMJ_2014_Feb_10_348_g1285_T344
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	birth	GO_BP_EXT	[10059]	[10064]	BMJ_2014_Feb_10_348_g1285_T111
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	birth	GO_BP_EXT	[10067]	[10072]	BMJ_2014_Feb_10_348_g1285_T112
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	subdural	UBERON_EXT	[10081]	[10089]	BMJ_2014_Feb_10_348_g1285_T345
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	intracerebral	UBERON_EXT	[10093]	[10106]	BMJ_2014_Feb_10_348_g1285_T346
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	spinal cord	UBERON_EXT	[10120]	[10131]	BMJ_2014_Feb_10_348_g1285_T347
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	peripheral nerve	UBERON_EXT	[10143]	[10159]	BMJ_2014_Feb_10_348_g1285_T348
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	discharge	GO_BP_EXT	[10187]	[10196]	BMJ_2014_Feb_10_348_g1285_T113
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	shoulder	UBERON_EXT	[10202]	[10210]	BMJ_2014_Feb_10_348_g1285_T349
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	suprapubic	UBERON_EXT	[10255]	[10265]	BMJ_2014_Feb_10_348_g1285_T350
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	delivery	GO_BP_EXT	[10350]	[10358]	BMJ_2014_Feb_10_348_g1285_T114
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	shoulder	UBERON_EXT	[10376]	[10384]	BMJ_2014_Feb_10_348_g1285_T351
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	deliver	GO_BP_EXT	[10439]	[10446]	BMJ_2014_Feb_10_348_g1285_T115
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_34	[9438]	[10468]	['Prespecified secondary infant outcomes included preterm birth (before 37 weeks); mortality (stillbirth (intrauterine fetal death after 20 weeks’ gestation and before birth), or infant death (death of a liveborn infant before hospital discharge, excluding lethal congenital anomalies)); weight >4000 g; hypoglycaemia requiring intravenous treatment; admission to neonatal intensive care unit or special care baby unit; hyperbilirubinaemia requiring phototherapy; nerve palsy (peripheral nerve injury, including spinal cord injury, present at discharge from hospital); fracture (basal skull or other fracture identified at birth); birth trauma (subdural or intracerebral haemorrhage, spinal cord injury, or peripheral nerve injury present at hospital discharge); or shoulder dystocia (one or more of moderate traction, suprapubic pressure, lithotomy position, McRoberts manoeuvre, rotation into the oblique plane, delivery of the posterior shoulder, cleidotomy, symphysiotomy, or Zavanelli manoeuvre to deliver the fetal shoulders).']	shoulders	UBERON_EXT	[10457]	[10466]	BMJ_2014_Feb_10_348_g1285_T352
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	blood	UBERON_EXT	[10542]	[10547]	BMJ_2014_Feb_10_348_g1285_T353
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	Hg	CHEBI_EXT	[10592]	[10594]	BMJ_2014_Feb_10_348_g1285_T14
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	gestational	GO_BP_EXT	[10659]	[10670]	BMJ_2014_Feb_10_348_g1285_T116
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	glucose	CHEBI_EXT	[10699]	[10706]	BMJ_2014_Feb_10_348_g1285_T15
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	glucose	CHEBI_EXT	[10748]	[10755]	BMJ_2014_Feb_10_348_g1285_T16
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	labour	GO_BP_EXT	[10928]	[10934]	BMJ_2014_Feb_10_348_g1285_T117
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	membranes	UBERON_EXT	[10950]	[10959]	BMJ_2014_Feb_10_348_g1285_T354
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	labour	GO_BP_EXT	[10967]	[10973]	BMJ_2014_Feb_10_348_g1285_T118
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	antibiotics	CHEBI_EXT	[11002]	[11013]	BMJ_2014_Feb_10_348_g1285_T17
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	labour	GO_BP_EXT	[11021]	[11027]	BMJ_2014_Feb_10_348_g1285_T119
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	labour	GO_BP_EXT	[11051]	[11057]	BMJ_2014_Feb_10_348_g1285_T120
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	antibiotic	CHEBI_EXT	[11059]	[11069]	BMJ_2014_Feb_10_348_g1285_T18
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	labour	GO_BP_EXT	[11081]	[11087]	BMJ_2014_Feb_10_348_g1285_T121
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	postpartum	GO_BP_EXT	[11108]	[11118]	BMJ_2014_Feb_10_348_g1285_T122
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	perineal	UBERON_EXT	[11142]	[11150]	BMJ_2014_Feb_10_348_g1285_T355
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	antibiotics	CHEBI_EXT	[11190]	[11201]	BMJ_2014_Feb_10_348_g1285_T19
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	postpartum	GO_BP_EXT	[11202]	[11212]	BMJ_2014_Feb_10_348_g1285_T123
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	postpartum	GO_BP_EXT	[11214]	[11224]	BMJ_2014_Feb_10_348_g1285_T124
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_35	[10469]	[11293]	['Prespecified secondary maternal outcomes included hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic ≥90 mm Hg on two occasions four or more hours apart) and pre-eclampsia27; gestational diabetes (positive 75g oral glucose tolerance test result with fasting blood glucose ≥5.5 mmol/L or 2 hour ≥7.8 mmol/L)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring antibiotics during labour; need for induction of labour; antibiotic use during labour; caesarean section; postpartum haemorrhage (>600 mL); perineal trauma; wound infection; endometritis; antibiotics postpartum; postpartum length of hospital stay; thromboembolic disease; and maternal death.']	death	GO_BP_EXT	[11287]	[11292]	BMJ_2014_Feb_10_348_g1285_T125
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_36	[11294]	[11773]	['In a post hoc analysis, we categorised gestational weight gain (defined as the difference in weight measured between 36 weeks’ gestation (or closest to birth) and the antenatal booking visit) as the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on early BMI category.12\n\nStatistical analysis\nAnalyses were performed on an intention to treat basis, according to the treatment group allocated at randomisation.']	gestational	GO_BP_EXT	[11333]	[11344]	BMJ_2014_Feb_10_348_g1285_T126
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_36	[11294]	[11773]	['In a post hoc analysis, we categorised gestational weight gain (defined as the difference in weight measured between 36 weeks’ gestation (or closest to birth) and the antenatal booking visit) as the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on early BMI category.12\n\nStatistical analysis\nAnalyses were performed on an intention to treat basis, according to the treatment group allocated at randomisation.']	gestation	GO_BP_EXT	[11421]	[11430]	BMJ_2014_Feb_10_348_g1285_T127
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_36	[11294]	[11773]	['In a post hoc analysis, we categorised gestational weight gain (defined as the difference in weight measured between 36 weeks’ gestation (or closest to birth) and the antenatal booking visit) as the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on early BMI category.12\n\nStatistical analysis\nAnalyses were performed on an intention to treat basis, according to the treatment group allocated at randomisation.']	birth	GO_BP_EXT	[11446]	[11451]	BMJ_2014_Feb_10_348_g1285_T128
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_36	[11294]	[11773]	['In a post hoc analysis, we categorised gestational weight gain (defined as the difference in weight measured between 36 weeks’ gestation (or closest to birth) and the antenatal booking visit) as the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on early BMI category.12\n\nStatistical analysis\nAnalyses were performed on an intention to treat basis, according to the treatment group allocated at randomisation.']	women	NCBITAXON_EXT	[11507]	[11512]	BMJ_2014_Feb_10_348_g1285_T253
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_43	[12527]	[12650]	['Outcomes derived from birth weight were additionally adjusted for maternal age, socioeconomic status, and maternal smoking.']	birth	GO_BP_EXT	[12549]	[12554]	BMJ_2014_Feb_10_348_g1285_T129
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_47	[12894]	[13212]	['We estimated that a sample size of 2180 women would have 80% statistical power (two tailed α level 0.05) to detect a 30% relative reduction28in the occurrence of infants born large for gestational age from 14.4% to 10.1%, allowing for 15% attrition.3\n\nResults\nThe figure outlines the flow of participants in the trial.']	women	NCBITAXON_EXT	[12934]	[12939]	BMJ_2014_Feb_10_348_g1285_T254
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_47	[12894]	[13212]	['We estimated that a sample size of 2180 women would have 80% statistical power (two tailed α level 0.05) to detect a 30% relative reduction28in the occurrence of infants born large for gestational age from 14.4% to 10.1%, allowing for 15% attrition.3\n\nResults\nThe figure outlines the flow of participants in the trial.']	women	UBERON_EXT	[12934]	[12939]	BMJ_2014_Feb_10_348_g1285_T356
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_47	[12894]	[13212]	['We estimated that a sample size of 2180 women would have 80% statistical power (two tailed α level 0.05) to detect a 30% relative reduction28in the occurrence of infants born large for gestational age from 14.4% to 10.1%, allowing for 15% attrition.3\n\nResults\nThe figure outlines the flow of participants in the trial.']	infants	UBERON_EXT	[13056]	[13063]	BMJ_2014_Feb_10_348_g1285_T357
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_47	[12894]	[13212]	['We estimated that a sample size of 2180 women would have 80% statistical power (two tailed α level 0.05) to detect a 30% relative reduction28in the occurrence of infants born large for gestational age from 14.4% to 10.1%, allowing for 15% attrition.3\n\nResults\nThe figure outlines the flow of participants in the trial.']	born	GO_BP_EXT	[13064]	[13068]	BMJ_2014_Feb_10_348_g1285_T130
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_47	[12894]	[13212]	['We estimated that a sample size of 2180 women would have 80% statistical power (two tailed α level 0.05) to detect a 30% relative reduction28in the occurrence of infants born large for gestational age from 14.4% to 10.1%, allowing for 15% attrition.3\n\nResults\nThe figure outlines the flow of participants in the trial.']	gestational	GO_BP_EXT	[13079]	[13090]	BMJ_2014_Feb_10_348_g1285_T131
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_48	[13213]	[13310]	['A total of 2152 women and 2142 liveborn infants were included in the intention to treat analyses.']	women	NCBITAXON_EXT	[13229]	[13234]	BMJ_2014_Feb_10_348_g1285_T255
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_48	[13213]	[13310]	['A total of 2152 women and 2142 liveborn infants were included in the intention to treat analyses.']	women	UBERON_EXT	[13229]	[13234]	BMJ_2014_Feb_10_348_g1285_T358
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_48	[13213]	[13310]	['A total of 2152 women and 2142 liveborn infants were included in the intention to treat analyses.']	infants	UBERON_EXT	[13253]	[13260]	BMJ_2014_Feb_10_348_g1285_T359
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_49	[13311]	[13464]	['There were two maternal deaths (motor vehicle collision in lifestyle advice group; and ruptured maternal splenic artery aneurysm in standard care group).']	deaths	GO_BP_EXT	[13335]	[13341]	BMJ_2014_Feb_10_348_g1285_T132
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_49	[13311]	[13464]	['There were two maternal deaths (motor vehicle collision in lifestyle advice group; and ruptured maternal splenic artery aneurysm in standard care group).']	splenic artery	UBERON_EXT	[13416]	[13430]	BMJ_2014_Feb_10_348_g1285_T360
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_50	[13465]	[13913]	['There were 10 stillborn infants (two from placental abruption, one from severe intrauterine growth restriction, one from acute chorioamnionitis, and one from motor vehicle collision in lifestyle advice group; and two from placental insufficiency, one from obstetric cholestasis, and two unexplained in standard care group) and two neonatal deaths (excluding lethal congenital anomalies) from complications of extreme prematurity, one in each group.']	infants	UBERON_EXT	[13489]	[13496]	BMJ_2014_Feb_10_348_g1285_T361
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_50	[13465]	[13913]	['There were 10 stillborn infants (two from placental abruption, one from severe intrauterine growth restriction, one from acute chorioamnionitis, and one from motor vehicle collision in lifestyle advice group; and two from placental insufficiency, one from obstetric cholestasis, and two unexplained in standard care group) and two neonatal deaths (excluding lethal congenital anomalies) from complications of extreme prematurity, one in each group.']	placental	UBERON_EXT	[13507]	[13516]	BMJ_2014_Feb_10_348_g1285_T362
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_50	[13465]	[13913]	['There were 10 stillborn infants (two from placental abruption, one from severe intrauterine growth restriction, one from acute chorioamnionitis, and one from motor vehicle collision in lifestyle advice group; and two from placental insufficiency, one from obstetric cholestasis, and two unexplained in standard care group) and two neonatal deaths (excluding lethal congenital anomalies) from complications of extreme prematurity, one in each group.']	intrauterine	UBERON_EXT	[13544]	[13556]	BMJ_2014_Feb_10_348_g1285_T363
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_50	[13465]	[13913]	['There were 10 stillborn infants (two from placental abruption, one from severe intrauterine growth restriction, one from acute chorioamnionitis, and one from motor vehicle collision in lifestyle advice group; and two from placental insufficiency, one from obstetric cholestasis, and two unexplained in standard care group) and two neonatal deaths (excluding lethal congenital anomalies) from complications of extreme prematurity, one in each group.']	growth	GO_BP_EXT	[13557]	[13563]	BMJ_2014_Feb_10_348_g1285_T133
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_50	[13465]	[13913]	['There were 10 stillborn infants (two from placental abruption, one from severe intrauterine growth restriction, one from acute chorioamnionitis, and one from motor vehicle collision in lifestyle advice group; and two from placental insufficiency, one from obstetric cholestasis, and two unexplained in standard care group) and two neonatal deaths (excluding lethal congenital anomalies) from complications of extreme prematurity, one in each group.']	placental	UBERON_EXT	[13687]	[13696]	BMJ_2014_Feb_10_348_g1285_T364
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_50	[13465]	[13913]	['There were 10 stillborn infants (two from placental abruption, one from severe intrauterine growth restriction, one from acute chorioamnionitis, and one from motor vehicle collision in lifestyle advice group; and two from placental insufficiency, one from obstetric cholestasis, and two unexplained in standard care group) and two neonatal deaths (excluding lethal congenital anomalies) from complications of extreme prematurity, one in each group.']	neonatal	UBERON_EXT	[13796]	[13804]	BMJ_2014_Feb_10_348_g1285_T365
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_50	[13465]	[13913]	['There were 10 stillborn infants (two from placental abruption, one from severe intrauterine growth restriction, one from acute chorioamnionitis, and one from motor vehicle collision in lifestyle advice group; and two from placental insufficiency, one from obstetric cholestasis, and two unexplained in standard care group) and two neonatal deaths (excluding lethal congenital anomalies) from complications of extreme prematurity, one in each group.']	deaths	GO_BP_EXT	[13805]	[13811]	BMJ_2014_Feb_10_348_g1285_T134
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_50	[13465]	[13913]	['There were 10 stillborn infants (two from placental abruption, one from severe intrauterine growth restriction, one from acute chorioamnionitis, and one from motor vehicle collision in lifestyle advice group; and two from placental insufficiency, one from obstetric cholestasis, and two unexplained in standard care group) and two neonatal deaths (excluding lethal congenital anomalies) from complications of extreme prematurity, one in each group.']	lethal	GO_BP_EXT	[13823]	[13829]	BMJ_2014_Feb_10_348_g1285_T135
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_52	[14002]	[14126]	['The median BMI of the cohort was 31.1 (interquartile range 27.9-35.8), with 42.1% of women being overweight and 57.9% obese.']	women	NCBITAXON_EXT	[14087]	[14092]	BMJ_2014_Feb_10_348_g1285_T256
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_52	[14002]	[14126]	['The median BMI of the cohort was 31.1 (interquartile range 27.9-35.8), with 42.1% of women being overweight and 57.9% obese.']	women	UBERON_EXT	[14087]	[14092]	BMJ_2014_Feb_10_348_g1285_T366
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_53	[14127]	[14236]	['Of women randomised to lifestyle advice, 86.7% attended their first dietary appointment and 77.2% the second.']	women	NCBITAXON_EXT	[14130]	[14135]	BMJ_2014_Feb_10_348_g1285_T257
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_53	[14127]	[14236]	['Of women randomised to lifestyle advice, 86.7% attended their first dietary appointment and 77.2% the second.']	women	UBERON_EXT	[14130]	[14135]	BMJ_2014_Feb_10_348_g1285_T367
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_54	[14237]	[14315]	['Adequate data were available for 2127 (99.3%) infants for the primary outcome.']	infants	UBERON_EXT	[14283]	[14290]	BMJ_2014_Feb_10_348_g1285_T368
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_55	[14316]	[14392]	['Missing values for the 15 remaining infants were imputed as described above.']	infants	UBERON_EXT	[14352]	[14359]	BMJ_2014_Feb_10_348_g1285_T369
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_56	[14394]	[14585]	['Caption (TABLE-WRAP): TABLE 1\n\nBaseline characteristics at trial entry in pregnant women with BMI ≥25 randomised to lifestyle advice or standard care who did not withdraw consent to use data.']	pregnant	GO_BP_EXT	[14468]	[14476]	BMJ_2014_Feb_10_348_g1285_T136
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_56	[14394]	[14585]	['Caption (TABLE-WRAP): TABLE 1\n\nBaseline characteristics at trial entry in pregnant women with BMI ≥25 randomised to lifestyle advice or standard care who did not withdraw consent to use data.']	women	NCBITAXON_EXT	[14477]	[14482]	BMJ_2014_Feb_10_348_g1285_T258
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_56	[14394]	[14585]	['Caption (TABLE-WRAP): TABLE 1\n\nBaseline characteristics at trial entry in pregnant women with BMI ≥25 randomised to lifestyle advice or standard care who did not withdraw consent to use data.']	women	UBERON_EXT	[14477]	[14482]	BMJ_2014_Feb_10_348_g1285_T370
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	women	NCBITAXON_EXT	[14622]	[14627]	BMJ_2014_Feb_10_348_g1285_T259
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	women	UBERON_EXT	[14622]	[14627]	BMJ_2014_Feb_10_348_g1285_T371
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	gestational	GO_BP_EXT	[14801]	[14812]	BMJ_2014_Feb_10_348_g1285_T137
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	Preterm	GO_BP_EXT	[15482]	[15489]	BMJ_2014_Feb_10_348_g1285_T138
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	birth57	GO_BP_EXT	[15490]	[15497]	BMJ_2014_Feb_10_348_g1285_T139
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	Stillbirth13	GO_BP_EXT	[15557]	[15569]	BMJ_2014_Feb_10_348_g1285_T140
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	Neonatal	UBERON_EXT	[15590]	[15598]	BMJ_2014_Feb_10_348_g1285_T372
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	death11	GO_BP_EXT	[15599]	[15606]	BMJ_2014_Feb_10_348_g1285_T141
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	Heart	UBERON_EXT	[15772]	[15777]	BMJ_2014_Feb_10_348_g1285_T373
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_57	[14586]	[16124]	['Figures are numbers (percentage) of women unless stated otherwiseCharacteristicLifestyle advice (n=1105)Standard care (n=1097)Total (n=2202)Mean (SD) maternal age (years)29.3 (5.4)29.6 ( 5.6)29.4 ( 5.5)Median (IQR) gestational age at entry (weeks)14.0 (11.9-17.0)14.1 (11.9-17.0)14.1 (11.9-17.0)Median (IQR) BMI31.0 (28.1-35.9)31.1 (27.7-35.6)31.1 (27.9-35.8)BMI category:25.0-29.9458 (41.4)468 (42.7)926 (42.1)30.0-34.9326 (29.5)318 (29.0)644 (29.2)35.0-39.9202 (18.3)183 (16.7)385 (17.5)≥40.0119 (10.8)128 (11.7)247 (11.2)Public patients1081 (97.8)1067 (97.3)2148 (97.5)Mean (SD) weight (kg)88.6 (17.3)88.2 (17.6)88.4 (17.4)Mena (SD) height (cm)164.9 (6.6)164.8 (6.5)164.8 (6.6)Race:White995 (90.0)998 (91.0)1993 (90.5)Asian26 (2.4)34 (3.1)60 (2.7)Indian40 (3.6)35 (3.2)75 (3.4)Other44 (4.0)30 (2.7)74 (3.4)Smokers154 (13.9)126 (11.5)280 (12.7)Nulliparous457 (41.4)441 (40.2)898 (40.8)Previous:Preterm birth57 (5.2)59 (5.4)116 (5.3)Pre-eclampsia46 (4.2)51 (4.6)97 (4.4)Stillbirth13 (1.2)6 (0.5)19 (0.9)Neonatal death11 (1.0)7 (0.6)18 (0.8)Caesarean section197 (17.8)214 (19.5)411 (18.7)Family history of:Diabetes288 (26.1)290 (26.4)578 (26.2)Hypertension389 (35.2)369 (33.6)758 (34.4)Heart disease187 (16.9)179 (16.3)366 (16.6)Index of socioeconomic disadvantage*:Unknown2 (0.2)1 (0.1)3 (0.1)1 (most disadvantaged)340 (30.8)321 (29.3)661 (30.0)2271 (24.5)264 (24.1)535 (24.3)3173 (15.7)174 (15.9)347 (15.8)4150 (13.6)178 (16.2)328 (14.9)5 (least disadvantaged)169 (15.3)159 (14.5)328 (14.9)\nIQR=interquartile range; BMI=body mass index.']	body	UBERON_EXT	[16108]	[16112]	BMJ_2014_Feb_10_348_g1285_T374
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_58	[16125]	[16552]	['*Socioeconomic index as measured by SEIFA (socioeconomic indexes for areas (www.abs.gov.au/websitedbs/censushome.nsf/home/seifa?opendocument&navpos=260))\nThere was no significant difference in the risk of infants born large for gestational age in the lifestyle advice group compared with standard care group (203/1075 (19%) v 224/1067 (21%); adjusted relative risk 0.90, 95% confidence interval 0.77 to 1.07; P=0.24) (table 2).']	infants	UBERON_EXT	[16330]	[16337]	BMJ_2014_Feb_10_348_g1285_T375
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_58	[16125]	[16552]	['*Socioeconomic index as measured by SEIFA (socioeconomic indexes for areas (www.abs.gov.au/websitedbs/censushome.nsf/home/seifa?opendocument&navpos=260))\nThere was no significant difference in the risk of infants born large for gestational age in the lifestyle advice group compared with standard care group (203/1075 (19%) v 224/1067 (21%); adjusted relative risk 0.90, 95% confidence interval 0.77 to 1.07; P=0.24) (table 2).']	born	GO_BP_EXT	[16338]	[16342]	BMJ_2014_Feb_10_348_g1285_T142
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_58	[16125]	[16552]	['*Socioeconomic index as measured by SEIFA (socioeconomic indexes for areas (www.abs.gov.au/websitedbs/censushome.nsf/home/seifa?opendocument&navpos=260))\nThere was no significant difference in the risk of infants born large for gestational age in the lifestyle advice group compared with standard care group (203/1075 (19%) v 224/1067 (21%); adjusted relative risk 0.90, 95% confidence interval 0.77 to 1.07; P=0.24) (table 2).']	gestational	GO_BP_EXT	[16353]	[16364]	BMJ_2014_Feb_10_348_g1285_T143
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_59	[16553]	[16828]	['Infants born to women allocated to lifestyle advice, however, were less likely to weigh above 4000 g (164/1075 (15%) v 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04) when compared with infants born to women allocated to standard care.']	born	GO_BP_EXT	[16561]	[16565]	BMJ_2014_Feb_10_348_g1285_T144
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_59	[16553]	[16828]	['Infants born to women allocated to lifestyle advice, however, were less likely to weigh above 4000 g (164/1075 (15%) v 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04) when compared with infants born to women allocated to standard care.']	women	NCBITAXON_EXT	[16569]	[16574]	BMJ_2014_Feb_10_348_g1285_T260
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_59	[16553]	[16828]	['Infants born to women allocated to lifestyle advice, however, were less likely to weigh above 4000 g (164/1075 (15%) v 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04) when compared with infants born to women allocated to standard care.']	infants	UBERON_EXT	[16779]	[16786]	BMJ_2014_Feb_10_348_g1285_T376
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_59	[16553]	[16828]	['Infants born to women allocated to lifestyle advice, however, were less likely to weigh above 4000 g (164/1075 (15%) v 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04) when compared with infants born to women allocated to standard care.']	born	GO_BP_EXT	[16787]	[16791]	BMJ_2014_Feb_10_348_g1285_T145
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_59	[16553]	[16828]	['Infants born to women allocated to lifestyle advice, however, were less likely to weigh above 4000 g (164/1075 (15%) v 201/1067 (19%); 0.82, 0.68 to 0.99; number needed to treat (NNT) 28, 15 to 263; P=0.04) when compared with infants born to women allocated to standard care.']	women	NCBITAXON_EXT	[16795]	[16800]	BMJ_2014_Feb_10_348_g1285_T261
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_60	[16830]	[16955]	['Caption (TABLE-WRAP): TABLE 2\n\nPrespecified outcomes in infants born to women with BMI ≥25 at trial entry by treatment group.']	infants	UBERON_EXT	[16886]	[16893]	BMJ_2014_Feb_10_348_g1285_T377
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_60	[16830]	[16955]	['Caption (TABLE-WRAP): TABLE 2\n\nPrespecified outcomes in infants born to women with BMI ≥25 at trial entry by treatment group.']	born	GO_BP_EXT	[16894]	[16898]	BMJ_2014_Feb_10_348_g1285_T146
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_60	[16830]	[16955]	['Caption (TABLE-WRAP): TABLE 2\n\nPrespecified outcomes in infants born to women with BMI ≥25 at trial entry by treatment group.']	women	NCBITAXON_EXT	[16902]	[16907]	BMJ_2014_Feb_10_348_g1285_T262
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_60	[16830]	[16955]	['Caption (TABLE-WRAP): TABLE 2\n\nPrespecified outcomes in infants born to women with BMI ≥25 at trial entry by treatment group.']	women	UBERON_EXT	[16902]	[16907]	BMJ_2014_Feb_10_348_g1285_T378
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_61	[16956]	[17652]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed dataOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valueLarge for gestational age203 (19)224 (21)0.90 (0.76 to 1.07), 0.230.90 (0.77 to 1.07), 0.24Major congenital anomaly25 (2)14 (1)1.76 (0.92 to 3.37), 0.091.77 (0.93 to 3.39), 0.08Birth weight above 4000 g164 (15)201 (19)0.81 (0.67 to 0.98), 0.030.82 (0.68 to 0.99), 0.04Hypoglycaemia requiring treatment107 (10)103 (10)1.03 (0.79 to 1.33), 0.851.02 (0.79 to 1.31), 0.91Admission to NICU or SCBU394 (37)385 (36)1.02 (0.91 to 1.14), 0.791.00 (0.90 to 1.12), 0.99Hyperbilirubinaemia requiring phototherapy73 (7)88 (8.']	women	NCBITAXON_EXT	[16982]	[16987]	BMJ_2014_Feb_10_348_g1285_T263
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_61	[16956]	[17652]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed dataOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valueLarge for gestational age203 (19)224 (21)0.90 (0.76 to 1.07), 0.230.90 (0.77 to 1.07), 0.24Major congenital anomaly25 (2)14 (1)1.76 (0.92 to 3.37), 0.091.77 (0.93 to 3.39), 0.08Birth weight above 4000 g164 (15)201 (19)0.81 (0.67 to 0.98), 0.030.82 (0.68 to 0.99), 0.04Hypoglycaemia requiring treatment107 (10)103 (10)1.03 (0.79 to 1.33), 0.851.02 (0.79 to 1.31), 0.91Admission to NICU or SCBU394 (37)385 (36)1.02 (0.91 to 1.14), 0.791.00 (0.90 to 1.12), 0.99Hyperbilirubinaemia requiring phototherapy73 (7)88 (8.']	women	UBERON_EXT	[16982]	[16987]	BMJ_2014_Feb_10_348_g1285_T379
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_61	[16956]	[17652]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed dataOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valueLarge for gestational age203 (19)224 (21)0.90 (0.76 to 1.07), 0.230.90 (0.77 to 1.07), 0.24Major congenital anomaly25 (2)14 (1)1.76 (0.92 to 3.37), 0.091.77 (0.93 to 3.39), 0.08Birth weight above 4000 g164 (15)201 (19)0.81 (0.67 to 0.98), 0.030.82 (0.68 to 0.99), 0.04Hypoglycaemia requiring treatment107 (10)103 (10)1.03 (0.79 to 1.33), 0.851.02 (0.79 to 1.31), 0.91Admission to NICU or SCBU394 (37)385 (36)1.02 (0.91 to 1.14), 0.791.00 (0.90 to 1.12), 0.99Hyperbilirubinaemia requiring phototherapy73 (7)88 (8.']	gestational	GO_BP_EXT	[17150]	[17161]	BMJ_2014_Feb_10_348_g1285_T147
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_62	[17652]	[17993]	[')0.82 (0.61 to 1.11), 0.190.81 (0.60 to 1.09), 0.16Nerve palsy4 (0.4)2 (0.2)(N/A), 0.69‡NAFracture4 (0.4)2 (0.2)(N/A), 0.69‡NABirth trauma6 (0.6)7 (0.7)0.85 (0.29 to 2.52), 0.77NAShoulder dystocia44 (4)35 (3)1.25 (0.81 to 1.93), 0.321.25 (0.81 to 1.93), 0.32\nNICU=neonatal intensive care unit; SCBU=special care baby unit; NA=not applicable.']	neonatal	UBERON_EXT	[17916]	[17924]	BMJ_2014_Feb_10_348_g1285_T380
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_62	[17652]	[17993]	[')0.82 (0.61 to 1.11), 0.190.81 (0.60 to 1.09), 0.16Nerve palsy4 (0.4)2 (0.2)(N/A), 0.69‡NAFracture4 (0.4)2 (0.2)(N/A), 0.69‡NABirth trauma6 (0.6)7 (0.7)0.85 (0.29 to 2.52), 0.77NAShoulder dystocia44 (4)35 (3)1.25 (0.81 to 1.93), 0.321.25 (0.81 to 1.93), 0.32\nNICU=neonatal intensive care unit; SCBU=special care baby unit; NA=not applicable.']	care	UBERON_EXT	[17935]	[17939]	BMJ_2014_Feb_10_348_g1285_T381
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_62	[17652]	[17993]	[')0.82 (0.61 to 1.11), 0.190.81 (0.60 to 1.09), 0.16Nerve palsy4 (0.4)2 (0.2)(N/A), 0.69‡NAFracture4 (0.4)2 (0.2)(N/A), 0.69‡NABirth trauma6 (0.6)7 (0.7)0.85 (0.29 to 2.52), 0.77NAShoulder dystocia44 (4)35 (3)1.25 (0.81 to 1.93), 0.321.25 (0.81 to 1.93), 0.32\nNICU=neonatal intensive care unit; SCBU=special care baby unit; NA=not applicable.']	baby	UBERON_EXT	[17964]	[17968]	BMJ_2014_Feb_10_348_g1285_T382
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_63	[17994]	[18025]	['*Includes all liveborn infants.']	infants	UBERON_EXT	[18017]	[18024]	BMJ_2014_Feb_10_348_g1285_T383
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_65	[18112]	[18235]	['Outcomes derived from birth weight were additionally adjusted for maternal age, socioeconomic status, and maternal smoking.']	birth	GO_BP_EXT	[18134]	[18139]	BMJ_2014_Feb_10_348_g1285_T148
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_67	[18274]	[18421]	['There was no significant difference in preterm birth before 37 weeks or infant admission to neonatal intensive care or special care unit (table 2).']	birth	GO_BP_EXT	[18321]	[18326]	BMJ_2014_Feb_10_348_g1285_T149
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_67	[18274]	[18421]	['There was no significant difference in preterm birth before 37 weeks or infant admission to neonatal intensive care or special care unit (table 2).']	infant	UBERON_EXT	[18346]	[18352]	BMJ_2014_Feb_10_348_g1285_T384
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_67	[18274]	[18421]	['There was no significant difference in preterm birth before 37 weeks or infant admission to neonatal intensive care or special care unit (table 2).']	neonatal	UBERON_EXT	[18366]	[18374]	BMJ_2014_Feb_10_348_g1285_T385
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_67	[18274]	[18421]	['There was no significant difference in preterm birth before 37 weeks or infant admission to neonatal intensive care or special care unit (table 2).']	care	UBERON_EXT	[18385]	[18389]	BMJ_2014_Feb_10_348_g1285_T386
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_68	[18422]	[18604]	['For women, there were no significant differences in risk of antenatal (table 3), labour, or birth (table 4)complications after the lifestyle intervention compared with standard care.']	women	NCBITAXON_EXT	[18426]	[18431]	BMJ_2014_Feb_10_348_g1285_T264
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_68	[18422]	[18604]	['For women, there were no significant differences in risk of antenatal (table 3), labour, or birth (table 4)complications after the lifestyle intervention compared with standard care.']	women	UBERON_EXT	[18426]	[18431]	BMJ_2014_Feb_10_348_g1285_T387
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_68	[18422]	[18604]	['For women, there were no significant differences in risk of antenatal (table 3), labour, or birth (table 4)complications after the lifestyle intervention compared with standard care.']	antenatal	GO_BP_EXT	[18482]	[18491]	BMJ_2014_Feb_10_348_g1285_T150
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_68	[18422]	[18604]	['For women, there were no significant differences in risk of antenatal (table 3), labour, or birth (table 4)complications after the lifestyle intervention compared with standard care.']	labour	GO_BP_EXT	[18503]	[18509]	BMJ_2014_Feb_10_348_g1285_T151
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_68	[18422]	[18604]	['For women, there were no significant differences in risk of antenatal (table 3), labour, or birth (table 4)complications after the lifestyle intervention compared with standard care.']	birth	GO_BP_EXT	[18514]	[18519]	BMJ_2014_Feb_10_348_g1285_T152
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_69	[18606]	[18734]	['Caption (TABLE-WRAP): TABLE 3\n\nPrespecified maternal antenatal outcomes in women with BMI ≥25 at trial entry by treatment group.']	antenatal	GO_BP_EXT	[18659]	[18668]	BMJ_2014_Feb_10_348_g1285_T153
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_69	[18606]	[18734]	['Caption (TABLE-WRAP): TABLE 3\n\nPrespecified maternal antenatal outcomes in women with BMI ≥25 at trial entry by treatment group.']	women	NCBITAXON_EXT	[18681]	[18686]	BMJ_2014_Feb_10_348_g1285_T265
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_69	[18606]	[18734]	['Caption (TABLE-WRAP): TABLE 3\n\nPrespecified maternal antenatal outcomes in women with BMI ≥25 at trial entry by treatment group.']	women	UBERON_EXT	[18681]	[18686]	BMJ_2014_Feb_10_348_g1285_T388
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_70	[18735]	[19657]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1080*)Standard care (n=1073*)Treatment effect (95% CI), P valueHypertension101 (9)94 (9)1.06 (0.81 to 1.39), 0.651.05 (0.81 to 1.38), 0.70Pre-eclampsia56 (5)53 (5)1.05 (0.73 to 1.51), 0.801.03 (0.71 to 1.47), 0.89Gestational diabetes148 (14)120 (11)1.22 (0.97 to 1.54), 0.091.21 (0.96 to 1.52), 0.11Antenatal admission166 (15)191 (18)0.86 (0.71 to 1.04), 0.130.86 (0.71 to 1.04), 0.13Mean (SD) antenatal length of stay*‡0.58 (2.11)0.85 (3.05)0.68 (0.50 to 0.93), 0.020.70 (0.51 to 0.95), 0.02Antepartum haemorrhage requiring admission16 (1.5)16 (1.5)0.99 (0.50 to 1.97), 0.981.00 (0.50 to 1.98), 0.99Preterm prelabour ruptured membranes9 (0.8)19 (1.8)0.47 (0.21 to 1.03), 0.06NAPrelabour ruptured membranes at term9 (0.8)9 (0.9)0.99 (0.39 to 2.48), 0.98NA\nNA=not applicable.']	women	NCBITAXON_EXT	[18761]	[18766]	BMJ_2014_Feb_10_348_g1285_T266
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_70	[18735]	[19657]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1080*)Standard care (n=1073*)Treatment effect (95% CI), P valueHypertension101 (9)94 (9)1.06 (0.81 to 1.39), 0.651.05 (0.81 to 1.38), 0.70Pre-eclampsia56 (5)53 (5)1.05 (0.73 to 1.51), 0.801.03 (0.71 to 1.47), 0.89Gestational diabetes148 (14)120 (11)1.22 (0.97 to 1.54), 0.091.21 (0.96 to 1.52), 0.11Antenatal admission166 (15)191 (18)0.86 (0.71 to 1.04), 0.130.86 (0.71 to 1.04), 0.13Mean (SD) antenatal length of stay*‡0.58 (2.11)0.85 (3.05)0.68 (0.50 to 0.93), 0.020.70 (0.51 to 0.95), 0.02Antepartum haemorrhage requiring admission16 (1.5)16 (1.5)0.99 (0.50 to 1.97), 0.981.00 (0.50 to 1.98), 0.99Preterm prelabour ruptured membranes9 (0.8)19 (1.8)0.47 (0.21 to 1.03), 0.06NAPrelabour ruptured membranes at term9 (0.8)9 (0.9)0.99 (0.39 to 2.48), 0.98NA\nNA=not applicable.']	women	UBERON_EXT	[18761]	[18766]	BMJ_2014_Feb_10_348_g1285_T389
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_70	[18735]	[19657]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1080*)Standard care (n=1073*)Treatment effect (95% CI), P valueHypertension101 (9)94 (9)1.06 (0.81 to 1.39), 0.651.05 (0.81 to 1.38), 0.70Pre-eclampsia56 (5)53 (5)1.05 (0.73 to 1.51), 0.801.03 (0.71 to 1.47), 0.89Gestational diabetes148 (14)120 (11)1.22 (0.97 to 1.54), 0.091.21 (0.96 to 1.52), 0.11Antenatal admission166 (15)191 (18)0.86 (0.71 to 1.04), 0.130.86 (0.71 to 1.04), 0.13Mean (SD) antenatal length of stay*‡0.58 (2.11)0.85 (3.05)0.68 (0.50 to 0.93), 0.020.70 (0.51 to 0.95), 0.02Antepartum haemorrhage requiring admission16 (1.5)16 (1.5)0.99 (0.50 to 1.97), 0.981.00 (0.50 to 1.98), 0.99Preterm prelabour ruptured membranes9 (0.8)19 (1.8)0.47 (0.21 to 1.03), 0.06NAPrelabour ruptured membranes at term9 (0.8)9 (0.9)0.99 (0.39 to 2.48), 0.98NA\nNA=not applicable.']	membranes9	UBERON_EXT	[19510]	[19520]	BMJ_2014_Feb_10_348_g1285_T390
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_70	[18735]	[19657]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1080*)Standard care (n=1073*)Treatment effect (95% CI), P valueHypertension101 (9)94 (9)1.06 (0.81 to 1.39), 0.651.05 (0.81 to 1.38), 0.70Pre-eclampsia56 (5)53 (5)1.05 (0.73 to 1.51), 0.801.03 (0.71 to 1.47), 0.89Gestational diabetes148 (14)120 (11)1.22 (0.97 to 1.54), 0.091.21 (0.96 to 1.52), 0.11Antenatal admission166 (15)191 (18)0.86 (0.71 to 1.04), 0.130.86 (0.71 to 1.04), 0.13Mean (SD) antenatal length of stay*‡0.58 (2.11)0.85 (3.05)0.68 (0.50 to 0.93), 0.020.70 (0.51 to 0.95), 0.02Antepartum haemorrhage requiring admission16 (1.5)16 (1.5)0.99 (0.50 to 1.97), 0.981.00 (0.50 to 1.98), 0.99Preterm prelabour ruptured membranes9 (0.8)19 (1.8)0.47 (0.21 to 1.03), 0.06NAPrelabour ruptured membranes at term9 (0.8)9 (0.9)0.99 (0.39 to 2.48), 0.98NA\nNA=not applicable.']	membranes	UBERON_EXT	[19580]	[19589]	BMJ_2014_Feb_10_348_g1285_T391
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_71	[19658]	[19715]	['*Includes all women who had liveborn or stillborn infant.']	women	NCBITAXON_EXT	[19672]	[19677]	BMJ_2014_Feb_10_348_g1285_T267
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_71	[19658]	[19715]	['*Includes all women who had liveborn or stillborn infant.']	women	UBERON_EXT	[19672]	[19677]	BMJ_2014_Feb_10_348_g1285_T392
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_71	[19658]	[19715]	['*Includes all women who had liveborn or stillborn infant.']	liveborn	GO_BP_EXT	[19686]	[19694]	BMJ_2014_Feb_10_348_g1285_T154
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_71	[19658]	[19715]	['*Includes all women who had liveborn or stillborn infant.']	infant	UBERON_EXT	[19708]	[19714]	BMJ_2014_Feb_10_348_g1285_T393
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_74	[19866]	[19992]	['Caption (TABLE-WRAP): TABLE 4\n\nPrespecified labour and birth outcomes in women with BMI ≥25 at trial entry by treatment group.']	labour	GO_BP_EXT	[19910]	[19916]	BMJ_2014_Feb_10_348_g1285_T155
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_74	[19866]	[19992]	['Caption (TABLE-WRAP): TABLE 4\n\nPrespecified labour and birth outcomes in women with BMI ≥25 at trial entry by treatment group.']	birth	GO_BP_EXT	[19921]	[19926]	BMJ_2014_Feb_10_348_g1285_T156
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_74	[19866]	[19992]	['Caption (TABLE-WRAP): TABLE 4\n\nPrespecified labour and birth outcomes in women with BMI ≥25 at trial entry by treatment group.']	women	NCBITAXON_EXT	[19939]	[19944]	BMJ_2014_Feb_10_348_g1285_T268
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_74	[19866]	[19992]	['Caption (TABLE-WRAP): TABLE 4\n\nPrespecified labour and birth outcomes in women with BMI ≥25 at trial entry by treatment group.']	women	UBERON_EXT	[19939]	[19944]	BMJ_2014_Feb_10_348_g1285_T394
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_75	[19993]	[21250]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valuePreterm birth62 (6)83 (8)0.75 (0.54 to 1.03), 0.070.74 (0.54 to 1.02), 0.07Chorioamnionitis requiring antibiotics27 (3)33 (3)0.81 (0.49 to 1.34), 0.410.78 (0.48 to 1.29), 0.34Induction of labour390 (36)378 (35)1.02 (0.91 to 1.15), 0.681.03 (0.92 to 1.15), 0.63Antibiotics during labour439 (41)454 (43)0.96 (0.87 to 1.06), 0.430.97 (0.88 to 1.07), 0.57Caesarean section370 (34)389 (37)0.94 (0.84 to 1.06), 0.330.95 (0.85 to 1.06), 0.34Postpartum haemorrhage >600 mL168 (18)177 (17)0.94 (0.77 to 1.14), 0.530.94 (0.77 to 1.14), 0.503rd/4th degree perineal trauma28 (3)20 (2)1.37 (0.78 to 2.43), 0.281.36 (0.77 to 2.40), 0.29Wound infection32 (3)30 (3)1.05 (0.65 to 1.72), 0.831.04 (0.64 to 1.70), 0.87Endometritis12 (1)10 (1)1.18 (0.51 to 2.72), 0.701.18 (0.51 to 2.72), 0.69Postpartum antibiotics99 (9)98 (9)1.00 (0.76 to 1.31), 1.000.98 (0.75 to 1.28), 0.90Mean (SD) postnatal length of stay (mother) (days)‡2.85 (1.79)2.91 (1.71)0.98 (0.93 to 1.03), 0.370.97 (0.93 to 1.02), 0.31Thromboembolic disease1 (0.1)2 (0.2)NA, 0.62§NA\nNA=not applicable.']	women	NCBITAXON_EXT	[20019]	[20024]	BMJ_2014_Feb_10_348_g1285_T269
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_75	[19993]	[21250]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valuePreterm birth62 (6)83 (8)0.75 (0.54 to 1.03), 0.070.74 (0.54 to 1.02), 0.07Chorioamnionitis requiring antibiotics27 (3)33 (3)0.81 (0.49 to 1.34), 0.410.78 (0.48 to 1.29), 0.34Induction of labour390 (36)378 (35)1.02 (0.91 to 1.15), 0.681.03 (0.92 to 1.15), 0.63Antibiotics during labour439 (41)454 (43)0.96 (0.87 to 1.06), 0.430.97 (0.88 to 1.07), 0.57Caesarean section370 (34)389 (37)0.94 (0.84 to 1.06), 0.330.95 (0.85 to 1.06), 0.34Postpartum haemorrhage >600 mL168 (18)177 (17)0.94 (0.77 to 1.14), 0.530.94 (0.77 to 1.14), 0.503rd/4th degree perineal trauma28 (3)20 (2)1.37 (0.78 to 2.43), 0.281.36 (0.77 to 2.40), 0.29Wound infection32 (3)30 (3)1.05 (0.65 to 1.72), 0.831.04 (0.64 to 1.70), 0.87Endometritis12 (1)10 (1)1.18 (0.51 to 2.72), 0.701.18 (0.51 to 2.72), 0.69Postpartum antibiotics99 (9)98 (9)1.00 (0.76 to 1.31), 1.000.98 (0.75 to 1.28), 0.90Mean (SD) postnatal length of stay (mother) (days)‡2.85 (1.79)2.91 (1.71)0.98 (0.93 to 1.03), 0.370.97 (0.93 to 1.02), 0.31Thromboembolic disease1 (0.1)2 (0.2)NA, 0.62§NA\nNA=not applicable.']	women	UBERON_EXT	[20019]	[20024]	BMJ_2014_Feb_10_348_g1285_T395
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_75	[19993]	[21250]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valuePreterm birth62 (6)83 (8)0.75 (0.54 to 1.03), 0.070.74 (0.54 to 1.02), 0.07Chorioamnionitis requiring antibiotics27 (3)33 (3)0.81 (0.49 to 1.34), 0.410.78 (0.48 to 1.29), 0.34Induction of labour390 (36)378 (35)1.02 (0.91 to 1.15), 0.681.03 (0.92 to 1.15), 0.63Antibiotics during labour439 (41)454 (43)0.96 (0.87 to 1.06), 0.430.97 (0.88 to 1.07), 0.57Caesarean section370 (34)389 (37)0.94 (0.84 to 1.06), 0.330.95 (0.85 to 1.06), 0.34Postpartum haemorrhage >600 mL168 (18)177 (17)0.94 (0.77 to 1.14), 0.530.94 (0.77 to 1.14), 0.503rd/4th degree perineal trauma28 (3)20 (2)1.37 (0.78 to 2.43), 0.281.36 (0.77 to 2.40), 0.29Wound infection32 (3)30 (3)1.05 (0.65 to 1.72), 0.831.04 (0.64 to 1.70), 0.87Endometritis12 (1)10 (1)1.18 (0.51 to 2.72), 0.701.18 (0.51 to 2.72), 0.69Postpartum antibiotics99 (9)98 (9)1.00 (0.76 to 1.31), 1.000.98 (0.75 to 1.28), 0.90Mean (SD) postnatal length of stay (mother) (days)‡2.85 (1.79)2.91 (1.71)0.98 (0.93 to 1.03), 0.370.97 (0.93 to 1.02), 0.31Thromboembolic disease1 (0.1)2 (0.2)NA, 0.62§NA\nNA=not applicable.']	birth62	GO_BP_EXT	[20212]	[20219]	BMJ_2014_Feb_10_348_g1285_T157
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_75	[19993]	[21250]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valuePreterm birth62 (6)83 (8)0.75 (0.54 to 1.03), 0.070.74 (0.54 to 1.02), 0.07Chorioamnionitis requiring antibiotics27 (3)33 (3)0.81 (0.49 to 1.34), 0.410.78 (0.48 to 1.29), 0.34Induction of labour390 (36)378 (35)1.02 (0.91 to 1.15), 0.681.03 (0.92 to 1.15), 0.63Antibiotics during labour439 (41)454 (43)0.96 (0.87 to 1.06), 0.430.97 (0.88 to 1.07), 0.57Caesarean section370 (34)389 (37)0.94 (0.84 to 1.06), 0.330.95 (0.85 to 1.06), 0.34Postpartum haemorrhage >600 mL168 (18)177 (17)0.94 (0.77 to 1.14), 0.530.94 (0.77 to 1.14), 0.503rd/4th degree perineal trauma28 (3)20 (2)1.37 (0.78 to 2.43), 0.281.36 (0.77 to 2.40), 0.29Wound infection32 (3)30 (3)1.05 (0.65 to 1.72), 0.831.04 (0.64 to 1.70), 0.87Endometritis12 (1)10 (1)1.18 (0.51 to 2.72), 0.701.18 (0.51 to 2.72), 0.69Postpartum antibiotics99 (9)98 (9)1.00 (0.76 to 1.31), 1.000.98 (0.75 to 1.28), 0.90Mean (SD) postnatal length of stay (mother) (days)‡2.85 (1.79)2.91 (1.71)0.98 (0.93 to 1.03), 0.370.97 (0.93 to 1.02), 0.31Thromboembolic disease1 (0.1)2 (0.2)NA, 0.62§NA\nNA=not applicable.']	antibiotics27	CHEBI_EXT	[20306]	[20319]	BMJ_2014_Feb_10_348_g1285_T20
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_75	[19993]	[21250]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valuePreterm birth62 (6)83 (8)0.75 (0.54 to 1.03), 0.070.74 (0.54 to 1.02), 0.07Chorioamnionitis requiring antibiotics27 (3)33 (3)0.81 (0.49 to 1.34), 0.410.78 (0.48 to 1.29), 0.34Induction of labour390 (36)378 (35)1.02 (0.91 to 1.15), 0.681.03 (0.92 to 1.15), 0.63Antibiotics during labour439 (41)454 (43)0.96 (0.87 to 1.06), 0.430.97 (0.88 to 1.07), 0.57Caesarean section370 (34)389 (37)0.94 (0.84 to 1.06), 0.330.95 (0.85 to 1.06), 0.34Postpartum haemorrhage >600 mL168 (18)177 (17)0.94 (0.77 to 1.14), 0.530.94 (0.77 to 1.14), 0.503rd/4th degree perineal trauma28 (3)20 (2)1.37 (0.78 to 2.43), 0.281.36 (0.77 to 2.40), 0.29Wound infection32 (3)30 (3)1.05 (0.65 to 1.72), 0.831.04 (0.64 to 1.70), 0.87Endometritis12 (1)10 (1)1.18 (0.51 to 2.72), 0.701.18 (0.51 to 2.72), 0.69Postpartum antibiotics99 (9)98 (9)1.00 (0.76 to 1.31), 1.000.98 (0.75 to 1.28), 0.90Mean (SD) postnatal length of stay (mother) (days)‡2.85 (1.79)2.91 (1.71)0.98 (0.93 to 1.03), 0.370.97 (0.93 to 1.02), 0.31Thromboembolic disease1 (0.1)2 (0.2)NA, 0.62§NA\nNA=not applicable.']	labour390	GO_BP_EXT	[20392]	[20401]	BMJ_2014_Feb_10_348_g1285_T158
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_75	[19993]	[21250]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valuePreterm birth62 (6)83 (8)0.75 (0.54 to 1.03), 0.070.74 (0.54 to 1.02), 0.07Chorioamnionitis requiring antibiotics27 (3)33 (3)0.81 (0.49 to 1.34), 0.410.78 (0.48 to 1.29), 0.34Induction of labour390 (36)378 (35)1.02 (0.91 to 1.15), 0.681.03 (0.92 to 1.15), 0.63Antibiotics during labour439 (41)454 (43)0.96 (0.87 to 1.06), 0.430.97 (0.88 to 1.07), 0.57Caesarean section370 (34)389 (37)0.94 (0.84 to 1.06), 0.330.95 (0.85 to 1.06), 0.34Postpartum haemorrhage >600 mL168 (18)177 (17)0.94 (0.77 to 1.14), 0.530.94 (0.77 to 1.14), 0.503rd/4th degree perineal trauma28 (3)20 (2)1.37 (0.78 to 2.43), 0.281.36 (0.77 to 2.40), 0.29Wound infection32 (3)30 (3)1.05 (0.65 to 1.72), 0.831.04 (0.64 to 1.70), 0.87Endometritis12 (1)10 (1)1.18 (0.51 to 2.72), 0.701.18 (0.51 to 2.72), 0.69Postpartum antibiotics99 (9)98 (9)1.00 (0.76 to 1.31), 1.000.98 (0.75 to 1.28), 0.90Mean (SD) postnatal length of stay (mother) (days)‡2.85 (1.79)2.91 (1.71)0.98 (0.93 to 1.03), 0.370.97 (0.93 to 1.02), 0.31Thromboembolic disease1 (0.1)2 (0.2)NA, 0.62§NA\nNA=not applicable.']	labour439	GO_BP_EXT	[20483]	[20492]	BMJ_2014_Feb_10_348_g1285_T159
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_75	[19993]	[21250]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valuePreterm birth62 (6)83 (8)0.75 (0.54 to 1.03), 0.070.74 (0.54 to 1.02), 0.07Chorioamnionitis requiring antibiotics27 (3)33 (3)0.81 (0.49 to 1.34), 0.410.78 (0.48 to 1.29), 0.34Induction of labour390 (36)378 (35)1.02 (0.91 to 1.15), 0.681.03 (0.92 to 1.15), 0.63Antibiotics during labour439 (41)454 (43)0.96 (0.87 to 1.06), 0.430.97 (0.88 to 1.07), 0.57Caesarean section370 (34)389 (37)0.94 (0.84 to 1.06), 0.330.95 (0.85 to 1.06), 0.34Postpartum haemorrhage >600 mL168 (18)177 (17)0.94 (0.77 to 1.14), 0.530.94 (0.77 to 1.14), 0.503rd/4th degree perineal trauma28 (3)20 (2)1.37 (0.78 to 2.43), 0.281.36 (0.77 to 2.40), 0.29Wound infection32 (3)30 (3)1.05 (0.65 to 1.72), 0.831.04 (0.64 to 1.70), 0.87Endometritis12 (1)10 (1)1.18 (0.51 to 2.72), 0.701.18 (0.51 to 2.72), 0.69Postpartum antibiotics99 (9)98 (9)1.00 (0.76 to 1.31), 1.000.98 (0.75 to 1.28), 0.90Mean (SD) postnatal length of stay (mother) (days)‡2.85 (1.79)2.91 (1.71)0.98 (0.93 to 1.03), 0.370.97 (0.93 to 1.02), 0.31Thromboembolic disease1 (0.1)2 (0.2)NA, 0.62§NA\nNA=not applicable.']	perineal	UBERON_EXT	[20749]	[20757]	BMJ_2014_Feb_10_348_g1285_T396
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_75	[19993]	[21250]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valuePreterm birth62 (6)83 (8)0.75 (0.54 to 1.03), 0.070.74 (0.54 to 1.02), 0.07Chorioamnionitis requiring antibiotics27 (3)33 (3)0.81 (0.49 to 1.34), 0.410.78 (0.48 to 1.29), 0.34Induction of labour390 (36)378 (35)1.02 (0.91 to 1.15), 0.681.03 (0.92 to 1.15), 0.63Antibiotics during labour439 (41)454 (43)0.96 (0.87 to 1.06), 0.430.97 (0.88 to 1.07), 0.57Caesarean section370 (34)389 (37)0.94 (0.84 to 1.06), 0.330.95 (0.85 to 1.06), 0.34Postpartum haemorrhage >600 mL168 (18)177 (17)0.94 (0.77 to 1.14), 0.530.94 (0.77 to 1.14), 0.503rd/4th degree perineal trauma28 (3)20 (2)1.37 (0.78 to 2.43), 0.281.36 (0.77 to 2.40), 0.29Wound infection32 (3)30 (3)1.05 (0.65 to 1.72), 0.831.04 (0.64 to 1.70), 0.87Endometritis12 (1)10 (1)1.18 (0.51 to 2.72), 0.701.18 (0.51 to 2.72), 0.69Postpartum antibiotics99 (9)98 (9)1.00 (0.76 to 1.31), 1.000.98 (0.75 to 1.28), 0.90Mean (SD) postnatal length of stay (mother) (days)‡2.85 (1.79)2.91 (1.71)0.98 (0.93 to 1.03), 0.370.97 (0.93 to 1.02), 0.31Thromboembolic disease1 (0.1)2 (0.2)NA, 0.62§NA\nNA=not applicable.']	antibiotics99	CHEBI_EXT	[20988]	[21001]	BMJ_2014_Feb_10_348_g1285_T21
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_75	[19993]	[21250]	['Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicatedOutcomeLifestyle advice (n=1075*)Standard care (n=1067*)Treatment effect (95% CI), P valuePreterm birth62 (6)83 (8)0.75 (0.54 to 1.03), 0.070.74 (0.54 to 1.02), 0.07Chorioamnionitis requiring antibiotics27 (3)33 (3)0.81 (0.49 to 1.34), 0.410.78 (0.48 to 1.29), 0.34Induction of labour390 (36)378 (35)1.02 (0.91 to 1.15), 0.681.03 (0.92 to 1.15), 0.63Antibiotics during labour439 (41)454 (43)0.96 (0.87 to 1.06), 0.430.97 (0.88 to 1.07), 0.57Caesarean section370 (34)389 (37)0.94 (0.84 to 1.06), 0.330.95 (0.85 to 1.06), 0.34Postpartum haemorrhage >600 mL168 (18)177 (17)0.94 (0.77 to 1.14), 0.530.94 (0.77 to 1.14), 0.503rd/4th degree perineal trauma28 (3)20 (2)1.37 (0.78 to 2.43), 0.281.36 (0.77 to 2.40), 0.29Wound infection32 (3)30 (3)1.05 (0.65 to 1.72), 0.831.04 (0.64 to 1.70), 0.87Endometritis12 (1)10 (1)1.18 (0.51 to 2.72), 0.701.18 (0.51 to 2.72), 0.69Postpartum antibiotics99 (9)98 (9)1.00 (0.76 to 1.31), 1.000.98 (0.75 to 1.28), 0.90Mean (SD) postnatal length of stay (mother) (days)‡2.85 (1.79)2.91 (1.71)0.98 (0.93 to 1.03), 0.370.97 (0.93 to 1.02), 0.31Thromboembolic disease1 (0.1)2 (0.2)NA, 0.62§NA\nNA=not applicable.']	postnatal	GO_BP_EXT	[21071]	[21080]	BMJ_2014_Feb_10_348_g1285_T160
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_76	[21251]	[21282]	['*Includes all liveborn infants.']	infants	UBERON_EXT	[21274]	[21281]	BMJ_2014_Feb_10_348_g1285_T397
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_80	[21470]	[21726]	['In a post hoc analysis, there was no difference in total gestational weight gain (9.39 (SD 5.74) kg in the lifestyle advice group v 9.44 (SD 5.77) kg in standard care; adjusted mean difference −0.04, −0.55 to 0.48; P=0.89) between the two groups (table 5).']	gestational	GO_BP_EXT	[21527]	[21538]	BMJ_2014_Feb_10_348_g1285_T161
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_81	[21727]	[22116]	['Furthermore, there were no significant differences between the two treatment groups in the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on BMI in early pregnancy (table 5).12\n\nCaption (TABLE-WRAP): TABLE 5\n\nPost hoc analysis of maternal gestational weight gain in women with BMI ≥25 at trial entry by treatment group.']	women	NCBITAXON_EXT	[21832]	[21837]	BMJ_2014_Feb_10_348_g1285_T270
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_81	[21727]	[22116]	['Furthermore, there were no significant differences between the two treatment groups in the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on BMI in early pregnancy (table 5).12\n\nCaption (TABLE-WRAP): TABLE 5\n\nPost hoc analysis of maternal gestational weight gain in women with BMI ≥25 at trial entry by treatment group.']	women	UBERON_EXT	[21832]	[21837]	BMJ_2014_Feb_10_348_g1285_T398
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_81	[21727]	[22116]	['Furthermore, there were no significant differences between the two treatment groups in the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on BMI in early pregnancy (table 5).12\n\nCaption (TABLE-WRAP): TABLE 5\n\nPost hoc analysis of maternal gestational weight gain in women with BMI ≥25 at trial entry by treatment group.']	pregnancy	GO_BP_EXT	[21951]	[21960]	BMJ_2014_Feb_10_348_g1285_T162
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_81	[21727]	[22116]	['Furthermore, there were no significant differences between the two treatment groups in the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on BMI in early pregnancy (table 5).12\n\nCaption (TABLE-WRAP): TABLE 5\n\nPost hoc analysis of maternal gestational weight gain in women with BMI ≥25 at trial entry by treatment group.']	gestational	GO_BP_EXT	[22036]	[22047]	BMJ_2014_Feb_10_348_g1285_T163
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_81	[21727]	[22116]	['Furthermore, there were no significant differences between the two treatment groups in the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on BMI in early pregnancy (table 5).12\n\nCaption (TABLE-WRAP): TABLE 5\n\nPost hoc analysis of maternal gestational weight gain in women with BMI ≥25 at trial entry by treatment group.']	women	NCBITAXON_EXT	[22063]	[22068]	BMJ_2014_Feb_10_348_g1285_T271
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_81	[21727]	[22116]	['Furthermore, there were no significant differences between the two treatment groups in the proportion of women whose weight gain was below, within, or exceeded the Institute of Medicine recommendations based on BMI in early pregnancy (table 5).12\n\nCaption (TABLE-WRAP): TABLE 5\n\nPost hoc analysis of maternal gestational weight gain in women with BMI ≥25 at trial entry by treatment group.']	women	UBERON_EXT	[22063]	[22068]	BMJ_2014_Feb_10_348_g1285_T399
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_83	[22926]	[23048]	['Outcomes derived from birth weight were additionally adjusted for maternal age, socioeconomic status and maternal smoking.']	birth	GO_BP_EXT	[22948]	[22953]	BMJ_2014_Feb_10_348_g1285_T164
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	women	NCBITAXON_EXT	[23210]	[23215]	BMJ_2014_Feb_10_348_g1285_T272
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	women	UBERON_EXT	[23210]	[23215]	BMJ_2014_Feb_10_348_g1285_T400
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	pregnancy	GO_BP_EXT	[23251]	[23260]	BMJ_2014_Feb_10_348_g1285_T165
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	infants	UBERON_EXT	[23289]	[23296]	BMJ_2014_Feb_10_348_g1285_T401
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	born	GO_BP_EXT	[23297]	[23301]	BMJ_2014_Feb_10_348_g1285_T166
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	gestational	GO_BP_EXT	[23312]	[23323]	BMJ_2014_Feb_10_348_g1285_T167
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	pregnancy	GO_BP_EXT	[23360]	[23369]	BMJ_2014_Feb_10_348_g1285_T168
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	birth	GO_BP_EXT	[23374]	[23379]	BMJ_2014_Feb_10_348_g1285_T169
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	birth	GO_BP_EXT	[23442]	[23447]	BMJ_2014_Feb_10_348_g1285_T170
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	lifestyle	GO_BP_EXT	[23615]	[23624]	BMJ_2014_Feb_10_348_g1285_T171
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	women	NCBITAXON_EXT	[23662]	[23667]	BMJ_2014_Feb_10_348_g1285_T273
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_85	[23119]	[23668]	['Discussion\n\nPrincipal findings\nOur findings indicate that provision of lifestyle advice to women who are overweight or obese during pregnancy does not reduce the risk of infants born large for gestational age or improve maternal outcomes of pregnancy and birth but is associated with a significant reduction in the risk of birth weight above 4000 g.\n\nStrengths and limitations\nOur randomised trial has several strengths, including being the largest to date to evaluate the effect of an antenatal lifestyle intervention for overweight or obese women.']	women	UBERON_EXT	[23662]	[23667]	BMJ_2014_Feb_10_348_g1285_T402
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_88	[24074]	[24241]	['We had few exclusion criteria, and the intensity of the intervention was realistically achievable within current publicly funded models of provision of antenatal care.']	antenatal care	GO_BP_EXT	[24226]	[24240]	BMJ_2014_Feb_10_348_g1285_T172
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_89	[24242]	[24523]	['In contrast with the findings reported in systematic reviews evaluating dietary interventions in overweight or obese pregnant women,171819which included smaller randomised trials, often of low methodological quality, we did not identify differences in mean gestational weight gain.']	pregnant	GO_BP_EXT	[24359]	[24367]	BMJ_2014_Feb_10_348_g1285_T173
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_89	[24242]	[24523]	['In contrast with the findings reported in systematic reviews evaluating dietary interventions in overweight or obese pregnant women,171819which included smaller randomised trials, often of low methodological quality, we did not identify differences in mean gestational weight gain.']	pregnant	UBERON_EXT	[24359]	[24367]	BMJ_2014_Feb_10_348_g1285_T403
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_89	[24242]	[24523]	['In contrast with the findings reported in systematic reviews evaluating dietary interventions in overweight or obese pregnant women,171819which included smaller randomised trials, often of low methodological quality, we did not identify differences in mean gestational weight gain.']	women	NCBITAXON_EXT	[24368]	[24373]	BMJ_2014_Feb_10_348_g1285_T274
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_89	[24242]	[24523]	['In contrast with the findings reported in systematic reviews evaluating dietary interventions in overweight or obese pregnant women,171819which included smaller randomised trials, often of low methodological quality, we did not identify differences in mean gestational weight gain.']	women	UBERON_EXT	[24368]	[24373]	BMJ_2014_Feb_10_348_g1285_T404
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_89	[24242]	[24523]	['In contrast with the findings reported in systematic reviews evaluating dietary interventions in overweight or obese pregnant women,171819which included smaller randomised trials, often of low methodological quality, we did not identify differences in mean gestational weight gain.']	gestational	GO_BP_EXT	[24499]	[24510]	BMJ_2014_Feb_10_348_g1285_T174
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_90	[24524]	[24843]	['While there has been considerable variation in the intensity of interventions provided across trials,171819ranging from single sessions with a dietician up to additional dietetic counselling sessions at each antenatal visit, most trials provided between three and six intervention sessions over the course of pregnancy.']	pregnancy	GO_BP_EXT	[24833]	[24842]	BMJ_2014_Feb_10_348_g1285_T175
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_91	[24844]	[25091]	['The intensity of our intervention was consistent with this approach, involving three face to face sessions and three telephone contacts and, importantly, was considered feasible to implement within current publicly funded models of maternity care.']	care	GO_BP_EXT	[25086]	[25090]	BMJ_2014_Feb_10_348_g1285_T176
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_92	[25092]	[25426]	['While increasing the intensity of the intervention might have resulted in differences in gestational weight gain, we consider this an impractical approach, both from a healthcare perspective where resources are limited, and from an individual woman’s perspective where additional attendance for visits could further affect compliance.']	gestational	GO_BP_EXT	[25181]	[25192]	BMJ_2014_Feb_10_348_g1285_T177
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_92	[25092]	[25426]	['While increasing the intensity of the intervention might have resulted in differences in gestational weight gain, we consider this an impractical approach, both from a healthcare perspective where resources are limited, and from an individual woman’s perspective where additional attendance for visits could further affect compliance.']	woman	NCBITAXON_EXT	[25335]	[25340]	BMJ_2014_Feb_10_348_g1285_T275
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_92	[25092]	[25426]	['While increasing the intensity of the intervention might have resulted in differences in gestational weight gain, we consider this an impractical approach, both from a healthcare perspective where resources are limited, and from an individual woman’s perspective where additional attendance for visits could further affect compliance.']	woman	UBERON_EXT	[25335]	[25340]	BMJ_2014_Feb_10_348_g1285_T405
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_94	[25598]	[25897]	['A potential limitation of our trial is the generalisability and external validity of our findings, our population being predominantly white and of high social disadvantage, with 60% of eligible women declining to participate, reflecting both a lack of interest and time because of other commitments.']	women	NCBITAXON_EXT	[25792]	[25797]	BMJ_2014_Feb_10_348_g1285_T276
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_94	[25598]	[25897]	['A potential limitation of our trial is the generalisability and external validity of our findings, our population being predominantly white and of high social disadvantage, with 60% of eligible women declining to participate, reflecting both a lack of interest and time because of other commitments.']	women	UBERON_EXT	[25792]	[25797]	BMJ_2014_Feb_10_348_g1285_T406
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_95	[25898]	[26051]	['Furthermore, not all women attended scheduled appointments with the dietitian, with only 87% attending their first and 77% their second dietary sessions.']	women	NCBITAXON_EXT	[25919]	[25924]	BMJ_2014_Feb_10_348_g1285_T277
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_95	[25898]	[26051]	['Furthermore, not all women attended scheduled appointments with the dietitian, with only 87% attending their first and 77% their second dietary sessions.']	women	UBERON_EXT	[25919]	[25924]	BMJ_2014_Feb_10_348_g1285_T407
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_96	[26052]	[26500]	['Compliance with intervention in trials involving overweight and obese pregnant women has been poorly reported in the literature to date.171819Of note, the Danish randomised trial by Vinter and colleagues29reported higher rates of attendance than were achieved in our trial, probably reflecting differences in characteristics of the study population, the women being of higher socioeconomic and educational status than the participants in our trial.']	pregnant	GO_BP_EXT	[26122]	[26130]	BMJ_2014_Feb_10_348_g1285_T178
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_96	[26052]	[26500]	['Compliance with intervention in trials involving overweight and obese pregnant women has been poorly reported in the literature to date.171819Of note, the Danish randomised trial by Vinter and colleagues29reported higher rates of attendance than were achieved in our trial, probably reflecting differences in characteristics of the study population, the women being of higher socioeconomic and educational status than the participants in our trial.']	women	NCBITAXON_EXT	[26131]	[26136]	BMJ_2014_Feb_10_348_g1285_T278
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_96	[26052]	[26500]	['Compliance with intervention in trials involving overweight and obese pregnant women has been poorly reported in the literature to date.171819Of note, the Danish randomised trial by Vinter and colleagues29reported higher rates of attendance than were achieved in our trial, probably reflecting differences in characteristics of the study population, the women being of higher socioeconomic and educational status than the participants in our trial.']	women	UBERON_EXT	[26131]	[26136]	BMJ_2014_Feb_10_348_g1285_T408
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_96	[26052]	[26500]	['Compliance with intervention in trials involving overweight and obese pregnant women has been poorly reported in the literature to date.171819Of note, the Danish randomised trial by Vinter and colleagues29reported higher rates of attendance than were achieved in our trial, probably reflecting differences in characteristics of the study population, the women being of higher socioeconomic and educational status than the participants in our trial.']	women	NCBITAXON_EXT	[26406]	[26411]	BMJ_2014_Feb_10_348_g1285_T279
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_96	[26052]	[26500]	['Compliance with intervention in trials involving overweight and obese pregnant women has been poorly reported in the literature to date.171819Of note, the Danish randomised trial by Vinter and colleagues29reported higher rates of attendance than were achieved in our trial, probably reflecting differences in characteristics of the study population, the women being of higher socioeconomic and educational status than the participants in our trial.']	women	UBERON_EXT	[26406]	[26411]	BMJ_2014_Feb_10_348_g1285_T409
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_97	[26502]	[27038]	['Comparison with other studies\nOur findings highlight the difficulties in limiting gestational weight gain at a population level, with 42% of women gaining in excess of the Institute of Medicine recommendations.12Research efforts to date have focused on limiting gestational weight gain, to the exclusion of adequate evaluation of relevant maternal and perinatal outcomes, based on a plausible assumption, although relatively untested by randomised trials, that lower weight gain results in improved outcomes in pregnancy and childbirth.']	gestational	GO_BP_EXT	[26584]	[26595]	BMJ_2014_Feb_10_348_g1285_T179
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_97	[26502]	[27038]	['Comparison with other studies\nOur findings highlight the difficulties in limiting gestational weight gain at a population level, with 42% of women gaining in excess of the Institute of Medicine recommendations.12Research efforts to date have focused on limiting gestational weight gain, to the exclusion of adequate evaluation of relevant maternal and perinatal outcomes, based on a plausible assumption, although relatively untested by randomised trials, that lower weight gain results in improved outcomes in pregnancy and childbirth.']	women	NCBITAXON_EXT	[26643]	[26648]	BMJ_2014_Feb_10_348_g1285_T280
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_97	[26502]	[27038]	['Comparison with other studies\nOur findings highlight the difficulties in limiting gestational weight gain at a population level, with 42% of women gaining in excess of the Institute of Medicine recommendations.12Research efforts to date have focused on limiting gestational weight gain, to the exclusion of adequate evaluation of relevant maternal and perinatal outcomes, based on a plausible assumption, although relatively untested by randomised trials, that lower weight gain results in improved outcomes in pregnancy and childbirth.']	women	UBERON_EXT	[26643]	[26648]	BMJ_2014_Feb_10_348_g1285_T410
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_97	[26502]	[27038]	['Comparison with other studies\nOur findings highlight the difficulties in limiting gestational weight gain at a population level, with 42% of women gaining in excess of the Institute of Medicine recommendations.12Research efforts to date have focused on limiting gestational weight gain, to the exclusion of adequate evaluation of relevant maternal and perinatal outcomes, based on a plausible assumption, although relatively untested by randomised trials, that lower weight gain results in improved outcomes in pregnancy and childbirth.']	gestational	GO_BP_EXT	[26764]	[26775]	BMJ_2014_Feb_10_348_g1285_T180
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_97	[26502]	[27038]	['Comparison with other studies\nOur findings highlight the difficulties in limiting gestational weight gain at a population level, with 42% of women gaining in excess of the Institute of Medicine recommendations.12Research efforts to date have focused on limiting gestational weight gain, to the exclusion of adequate evaluation of relevant maternal and perinatal outcomes, based on a plausible assumption, although relatively untested by randomised trials, that lower weight gain results in improved outcomes in pregnancy and childbirth.']	perinatal	GO_BP_EXT	[26854]	[26863]	BMJ_2014_Feb_10_348_g1285_T181
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_97	[26502]	[27038]	['Comparison with other studies\nOur findings highlight the difficulties in limiting gestational weight gain at a population level, with 42% of women gaining in excess of the Institute of Medicine recommendations.12Research efforts to date have focused on limiting gestational weight gain, to the exclusion of adequate evaluation of relevant maternal and perinatal outcomes, based on a plausible assumption, although relatively untested by randomised trials, that lower weight gain results in improved outcomes in pregnancy and childbirth.']	perinatal	UBERON_EXT	[26854]	[26863]	BMJ_2014_Feb_10_348_g1285_T411
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_97	[26502]	[27038]	['Comparison with other studies\nOur findings highlight the difficulties in limiting gestational weight gain at a population level, with 42% of women gaining in excess of the Institute of Medicine recommendations.12Research efforts to date have focused on limiting gestational weight gain, to the exclusion of adequate evaluation of relevant maternal and perinatal outcomes, based on a plausible assumption, although relatively untested by randomised trials, that lower weight gain results in improved outcomes in pregnancy and childbirth.']	pregnancy	GO_BP_EXT	[27013]	[27022]	BMJ_2014_Feb_10_348_g1285_T182
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_97	[26502]	[27038]	['Comparison with other studies\nOur findings highlight the difficulties in limiting gestational weight gain at a population level, with 42% of women gaining in excess of the Institute of Medicine recommendations.12Research efforts to date have focused on limiting gestational weight gain, to the exclusion of adequate evaluation of relevant maternal and perinatal outcomes, based on a plausible assumption, although relatively untested by randomised trials, that lower weight gain results in improved outcomes in pregnancy and childbirth.']	childbirth	GO_BP_EXT	[27027]	[27037]	BMJ_2014_Feb_10_348_g1285_T183
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_98	[27039]	[27245]	['Gestational weight gain as a measure incorporates the effects of maternal fat deposition, pregnancy related plasma volume expansion, peripheral oedema, placental mass, fetal mass, and amniotic fluid volume.']	Gestational	GO_BP_EXT	[27039]	[27050]	BMJ_2014_Feb_10_348_g1285_T184
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_98	[27039]	[27245]	['Gestational weight gain as a measure incorporates the effects of maternal fat deposition, pregnancy related plasma volume expansion, peripheral oedema, placental mass, fetal mass, and amniotic fluid volume.']	fat	CHEBI_EXT	[27113]	[27116]	BMJ_2014_Feb_10_348_g1285_T22
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_98	[27039]	[27245]	['Gestational weight gain as a measure incorporates the effects of maternal fat deposition, pregnancy related plasma volume expansion, peripheral oedema, placental mass, fetal mass, and amniotic fluid volume.']	fat	CHEBI_EXT	[27113]	[27116]	BMJ_2014_Feb_10_348_g1285_T412
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_98	[27039]	[27245]	['Gestational weight gain as a measure incorporates the effects of maternal fat deposition, pregnancy related plasma volume expansion, peripheral oedema, placental mass, fetal mass, and amniotic fluid volume.']	pregnancy	GO_BP_EXT	[27129]	[27138]	BMJ_2014_Feb_10_348_g1285_T185
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_98	[27039]	[27245]	['Gestational weight gain as a measure incorporates the effects of maternal fat deposition, pregnancy related plasma volume expansion, peripheral oedema, placental mass, fetal mass, and amniotic fluid volume.']	plasma	UBERON_EXT	[27147]	[27153]	BMJ_2014_Feb_10_348_g1285_T413
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_98	[27039]	[27245]	['Gestational weight gain as a measure incorporates the effects of maternal fat deposition, pregnancy related plasma volume expansion, peripheral oedema, placental mass, fetal mass, and amniotic fluid volume.']	placental	UBERON_EXT	[27191]	[27200]	BMJ_2014_Feb_10_348_g1285_T414
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_98	[27039]	[27245]	['Gestational weight gain as a measure incorporates the effects of maternal fat deposition, pregnancy related plasma volume expansion, peripheral oedema, placental mass, fetal mass, and amniotic fluid volume.']	fetal	UBERON_EXT	[27207]	[27212]	BMJ_2014_Feb_10_348_g1285_T415
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_98	[27039]	[27245]	['Gestational weight gain as a measure incorporates the effects of maternal fat deposition, pregnancy related plasma volume expansion, peripheral oedema, placental mass, fetal mass, and amniotic fluid volume.']	amniotic fluid	UBERON_EXT	[27223]	[27237]	BMJ_2014_Feb_10_348_g1285_T416
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	adipose tissue	UBERON_EXT	[27367]	[27381]	BMJ_2014_Feb_10_348_g1285_T417
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	pregnancy	GO_BP_EXT	[27452]	[27461]	BMJ_2014_Feb_10_348_g1285_T186
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	child	NCBITAXON_EXT	[27513]	[27518]	BMJ_2014_Feb_10_348_g1285_T281
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	child	UBERON_EXT	[27513]	[27518]	BMJ_2014_Feb_10_348_g1285_T418
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	growth	GO_BP_EXT	[27659]	[27665]	BMJ_2014_Feb_10_348_g1285_T187
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	consumption	GO_BP_EXT	[27727]	[27738]	BMJ_2014_Feb_10_348_g1285_T188
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	polyunsaturated	CHEBI_EXT	[27757]	[27772]	BMJ_2014_Feb_10_348_g1285_T23
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	fatty	CHEBI_EXT	[27773]	[27778]	BMJ_2014_Feb_10_348_g1285_T419
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	fatty acids	CHEBI_EXT	[27773]	[27784]	BMJ_2014_Feb_10_348_g1285_T24
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	childhood	UBERON_EXT	[27818]	[27827]	BMJ_2014_Feb_10_348_g1285_T420
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	skinfold	UBERON_EXT	[27853]	[27861]	BMJ_2014_Feb_10_348_g1285_T421
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	fat	CHEBI_EXT	[27891]	[27894]	BMJ_2014_Feb_10_348_g1285_T25
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	fat	CHEBI_EXT	[27891]	[27894]	BMJ_2014_Feb_10_348_g1285_T422
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	growth	GO_BP_EXT	[28072]	[28078]	BMJ_2014_Feb_10_348_g1285_T189
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_99	[27246]	[28110]	['It is difficult, however, to separate the relative contribution of each of these components, with maternal deposition of adipose tissue likely to have the greatest causal impact in terms of both short term pregnancy related outcomes and the longer term health of the child.30\nWhile the effect of any changes in maternal dietary intake, including specific nutritional components, and physical activity on in utero growth remains to be determined, observational studies suggest that consumption of a diet high in polyunsaturated fatty acids is associated with reduced early childhood adiposity as measured by skinfold thickness31and predictive of fat mass determined by DEXA at ages 4 and 6 years.32Together, these findings highlight the potential impact of relatively modest changes in the quality of maternal diet on in utero growth and future childhood adiposity.']	childhood	UBERON_EXT	[28090]	[28099]	BMJ_2014_Feb_10_348_g1285_T423
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	born	GO_BP_EXT	[28163]	[28167]	BMJ_2014_Feb_10_348_g1285_T190
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	gestational	GO_BP_EXT	[28178]	[28189]	BMJ_2014_Feb_10_348_g1285_T191
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	infant	UBERON_EXT	[28283]	[28289]	BMJ_2014_Feb_10_348_g1285_T424
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	born	GO_BP_EXT	[28296]	[28300]	BMJ_2014_Feb_10_348_g1285_T192
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	infants	UBERON_EXT	[28360]	[28367]	BMJ_2014_Feb_10_348_g1285_T425
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	birth	GO_BP_EXT	[28373]	[28378]	BMJ_2014_Feb_10_348_g1285_T193
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	preterm	GO_BP_EXT	[28495]	[28502]	BMJ_2014_Feb_10_348_g1285_T194
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	birth	GO_BP_EXT	[28503]	[28508]	BMJ_2014_Feb_10_348_g1285_T195
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	gestational	GO_BP_EXT	[28543]	[28554]	BMJ_2014_Feb_10_348_g1285_T196
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_100	[28111]	[28601]	['We did not find a difference in the risk of infants born large for gestational age, although our intervention was associated with a significant reduction in the risk of an infant being born weighing above 4000 g. This reduction in the proportion of infants with birth weight above 4000 g could reflect a chance event, which occurred despite a non-significant reduction in the risk of preterm birth and a non-significant increase in gestational diabetes for women receiving lifestyle advice.']	women	NCBITAXON_EXT	[28568]	[28573]	BMJ_2014_Feb_10_348_g1285_T282
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	infants	UBERON_EXT	[28757]	[28764]	BMJ_2014_Feb_10_348_g1285_T426
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	born	GO_BP_EXT	[28765]	[28769]	BMJ_2014_Feb_10_348_g1285_T197
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	women	NCBITAXON_EXT	[28793]	[28798]	BMJ_2014_Feb_10_348_g1285_T283
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	women	UBERON_EXT	[28793]	[28798]	BMJ_2014_Feb_10_348_g1285_T427
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	infants	UBERON_EXT	[28940]	[28947]	BMJ_2014_Feb_10_348_g1285_T428
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	born	GO_BP_EXT	[28948]	[28952]	BMJ_2014_Feb_10_348_g1285_T198
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	women	NCBITAXON_EXT	[28956]	[28961]	BMJ_2014_Feb_10_348_g1285_T284
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	women	UBERON_EXT	[28956]	[28961]	BMJ_2014_Feb_10_348_g1285_T429
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	birthweight	GO_BP_EXT	[29007]	[29018]	BMJ_2014_Feb_10_348_g1285_T199
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	infants	UBERON_EXT	[29133]	[29140]	BMJ_2014_Feb_10_348_g1285_T430
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_101	[28602]	[29164]	['Alternately, however, these findings are consistent with those of Sebire and colleagues,33who, using a large UK population based cohort, showed that while infants born to overweight or obese women were more likely to have weight at the upper end of the spectrum, there was little change in the remainder of the distribution compared with infants born to women of normal BMI.33While this is similar to the birthweight findings in our standard care group, it is plausible that our intervention successfully reduced the proportion of infants with high birth weight.']	birth	GO_BP_EXT	[29151]	[29156]	BMJ_2014_Feb_10_348_g1285_T200
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	infant	UBERON_EXT	[29168]	[29174]	BMJ_2014_Feb_10_348_g1285_T431
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	birth	GO_BP_EXT	[29175]	[29180]	BMJ_2014_Feb_10_348_g1285_T201
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	women	NCBITAXON_EXT	[29370]	[29375]	BMJ_2014_Feb_10_348_g1285_T285
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	infant	UBERON_EXT	[29409]	[29415]	BMJ_2014_Feb_10_348_g1285_T432
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	delivery	GO_BP_EXT	[29457]	[29465]	BMJ_2014_Feb_10_348_g1285_T202
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	birth	GO_BP_EXT	[29574]	[29579]	BMJ_2014_Feb_10_348_g1285_T203
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	childhood	UBERON_EXT	[29677]	[29686]	BMJ_2014_Feb_10_348_g1285_T433
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	adulthood	UBERON_EXT	[29691]	[29700]	BMJ_2014_Feb_10_348_g1285_T434
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	birth	GO_BP_EXT	[29719]	[29724]	BMJ_2014_Feb_10_348_g1285_T204
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	birth	GO_BP_EXT	[29896]	[29901]	BMJ_2014_Feb_10_348_g1285_T205
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	infants	UBERON_EXT	[30089]	[30096]	BMJ_2014_Feb_10_348_g1285_T435
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	born	GO_BP_EXT	[30097]	[30101]	BMJ_2014_Feb_10_348_g1285_T206
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	women	NCBITAXON_EXT	[30105]	[30110]	BMJ_2014_Feb_10_348_g1285_T286
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	birth	GO_BP_EXT	[30220]	[30225]	BMJ_2014_Feb_10_348_g1285_T207
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_102	[29165]	[30284]	['As infant birth weight above 4000 g was a secondary outcome in our trial, it will be important to evaluate this finding in ongoing randomised trials evaluating the effect of dietary interventions in obese women.34\nThe immediate consequences of infant macrosomia and its associated effects on delivery are well described.35There is, however, increasing evidence of a persisting longer term health legacy, with birth weight above 4000 g independently associated with an increased risk of overweight and obesity in childhood and adulthood.3637Specifically, birth weight greater than 4000 g has been associated with a twofold increased risk of obesity at age 4 years3839and beyond,3637highlighting the public health importance of high birth weight and of evaluating interventions that target the in utero environment in the short and long term prevention of obesity.40It will therefore be important to continue to follow-up the infants born to women in this trial to evaluate if there is any effect of the observed 18% relative risk reduction in incidence of birth weight above 4000 g on subsequent early childhood obesity.']	childhood	UBERON_EXT	[30266]	[30275]	BMJ_2014_Feb_10_348_g1285_T436
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_103	[30286]	[30704]	['Conclusions and policy implications\nTo date, there has been a lack of robust clinical outcome data from randomised trials on the effects of providing an antenatal dietary and lifestyle intervention for pregnant women who are overweight or obese, the research focus being on “gestational weight gain, at the expense of adequate power for clinical outcomes.”41Our trial dealt with this highlighted gap in the literature.']	pregnant	GO_BP_EXT	[30488]	[30496]	BMJ_2014_Feb_10_348_g1285_T208
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_103	[30286]	[30704]	['Conclusions and policy implications\nTo date, there has been a lack of robust clinical outcome data from randomised trials on the effects of providing an antenatal dietary and lifestyle intervention for pregnant women who are overweight or obese, the research focus being on “gestational weight gain, at the expense of adequate power for clinical outcomes.”41Our trial dealt with this highlighted gap in the literature.']	women	NCBITAXON_EXT	[30497]	[30502]	BMJ_2014_Feb_10_348_g1285_T287
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_103	[30286]	[30704]	['Conclusions and policy implications\nTo date, there has been a lack of robust clinical outcome data from randomised trials on the effects of providing an antenatal dietary and lifestyle intervention for pregnant women who are overweight or obese, the research focus being on “gestational weight gain, at the expense of adequate power for clinical outcomes.”41Our trial dealt with this highlighted gap in the literature.']	gestational	GO_BP_EXT	[30561]	[30572]	BMJ_2014_Feb_10_348_g1285_T209
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_104	[30705]	[31152]	['Our results indicate that while provision of an antenatal dietary and lifestyle intervention did not reduce the incidence of infants born large for gestational age, it was effective in reducing the risk of high infant birth weight, above 4000 g. The intervention provided was not associated with improvements in the various maternal pregnancy and birth outcomes, which are documented to occur more commonly among women who are overweight or obese.']	infants	UBERON_EXT	[30830]	[30837]	BMJ_2014_Feb_10_348_g1285_T437
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_104	[30705]	[31152]	['Our results indicate that while provision of an antenatal dietary and lifestyle intervention did not reduce the incidence of infants born large for gestational age, it was effective in reducing the risk of high infant birth weight, above 4000 g. The intervention provided was not associated with improvements in the various maternal pregnancy and birth outcomes, which are documented to occur more commonly among women who are overweight or obese.']	born	GO_BP_EXT	[30838]	[30842]	BMJ_2014_Feb_10_348_g1285_T210
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_104	[30705]	[31152]	['Our results indicate that while provision of an antenatal dietary and lifestyle intervention did not reduce the incidence of infants born large for gestational age, it was effective in reducing the risk of high infant birth weight, above 4000 g. The intervention provided was not associated with improvements in the various maternal pregnancy and birth outcomes, which are documented to occur more commonly among women who are overweight or obese.']	gestational	GO_BP_EXT	[30853]	[30864]	BMJ_2014_Feb_10_348_g1285_T211
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_104	[30705]	[31152]	['Our results indicate that while provision of an antenatal dietary and lifestyle intervention did not reduce the incidence of infants born large for gestational age, it was effective in reducing the risk of high infant birth weight, above 4000 g. The intervention provided was not associated with improvements in the various maternal pregnancy and birth outcomes, which are documented to occur more commonly among women who are overweight or obese.']	infant	UBERON_EXT	[30916]	[30922]	BMJ_2014_Feb_10_348_g1285_T438
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_104	[30705]	[31152]	['Our results indicate that while provision of an antenatal dietary and lifestyle intervention did not reduce the incidence of infants born large for gestational age, it was effective in reducing the risk of high infant birth weight, above 4000 g. The intervention provided was not associated with improvements in the various maternal pregnancy and birth outcomes, which are documented to occur more commonly among women who are overweight or obese.']	birth	GO_BP_EXT	[30923]	[30928]	BMJ_2014_Feb_10_348_g1285_T212
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_104	[30705]	[31152]	['Our results indicate that while provision of an antenatal dietary and lifestyle intervention did not reduce the incidence of infants born large for gestational age, it was effective in reducing the risk of high infant birth weight, above 4000 g. The intervention provided was not associated with improvements in the various maternal pregnancy and birth outcomes, which are documented to occur more commonly among women who are overweight or obese.']	pregnancy	GO_BP_EXT	[31038]	[31047]	BMJ_2014_Feb_10_348_g1285_T213
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_104	[30705]	[31152]	['Our results indicate that while provision of an antenatal dietary and lifestyle intervention did not reduce the incidence of infants born large for gestational age, it was effective in reducing the risk of high infant birth weight, above 4000 g. The intervention provided was not associated with improvements in the various maternal pregnancy and birth outcomes, which are documented to occur more commonly among women who are overweight or obese.']	birth	GO_BP_EXT	[31052]	[31057]	BMJ_2014_Feb_10_348_g1285_T214
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_104	[30705]	[31152]	['Our results indicate that while provision of an antenatal dietary and lifestyle intervention did not reduce the incidence of infants born large for gestational age, it was effective in reducing the risk of high infant birth weight, above 4000 g. The intervention provided was not associated with improvements in the various maternal pregnancy and birth outcomes, which are documented to occur more commonly among women who are overweight or obese.']	women	NCBITAXON_EXT	[31118]	[31123]	BMJ_2014_Feb_10_348_g1285_T288
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	drugs	CHEBI_EXT	[31434]	[31439]	BMJ_2014_Feb_10_348_g1285_T26
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	metformin	CHEBI_EXT	[31451]	[31460]	BMJ_2014_Feb_10_348_g1285_T27
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	pregnancy	GO_BP_EXT	[31579]	[31588]	BMJ_2014_Feb_10_348_g1285_T215
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	gestational	GO_BP_EXT	[31622]	[31633]	BMJ_2014_Feb_10_348_g1285_T216
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	pregnancy	GO_BP_EXT	[31713]	[31722]	BMJ_2014_Feb_10_348_g1285_T217
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	childbirth	GO_BP_EXT	[31727]	[31737]	BMJ_2014_Feb_10_348_g1285_T218
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	gestational	GO_BP_EXT	[31856]	[31867]	BMJ_2014_Feb_10_348_g1285_T219
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	pregnant	GO_BP_EXT	[32073]	[32081]	BMJ_2014_Feb_10_348_g1285_T220
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	women	NCBITAXON_EXT	[32082]	[32087]	BMJ_2014_Feb_10_348_g1285_T289
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	born	GO_BP_EXT	[32180]	[32184]	BMJ_2014_Feb_10_348_g1285_T221
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	gestational	GO_BP_EXT	[32195]	[32206]	BMJ_2014_Feb_10_348_g1285_T222
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	pregnancy	GO_BP_EXT	[32236]	[32245]	BMJ_2014_Feb_10_348_g1285_T223
BMJ_2014_Feb_10_348_g1285	BMJ_2014_Feb_10_348_g1285_106	[31389]	[32281]	['Alternate approaches might entail the use of drugs, including metformin, which is currently being evaluated.4243\n\nWhat is already known on this topic\nOverweight and obesity is common during pregnancy\nIncreasing maternal BMI and high gestational weight gain are both associated with an increased risk of complications during pregnancy and childbirth\nSystematic reviews have indicated that while antenatal dietary and lifestyle interventions seem effective in limiting gestational weight gain, the effect on clinically relevant outcomes remains to be determined\n\nWhat this study adds\nThe findings of this randomised trial indicate that providing a dietary and lifestyle intervention to pregnant women who are overweight or obese was not associated with a reduction in the incidence of infants born large for gestational age or in improving maternal pregnancy and birth outcomes\n\nPubMed Central:']	birth	GO_BP_EXT	[32250]	[32255]	BMJ_2014_Feb_10_348_g1285_T224
